Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3020682	u-albkre	mg/mmol (mg/mmol)	66101	189420	0.40%
3020682	u-albkre	— (—)	65845	198116	100.00%	Distribution not available
3020682	nu-albkrea	— (—)	11219	34864	100.00%	Distribution not available
3020682	u-albkrea	— (—)	7664	15491	100.00%	Distribution not available
3020682	nu-albkrea	mg/mmol (mg/mmol)	6330	10555	0.00%
3020682	u-albkrea	mg/mmol (mg/mmol)	5761	10479	0.00%
3020682	u-alb/kre	mg/mmol (mg/mmol)	1357	2520	0.00%
3020682	u-alb/kre	— (—)	1294	2353	100.00%	Distribution not available
3020682	nu-albkre	— (—)	1105	1697	100.00%	Distribution not available
3020682	u-alb/krea	— (—)	522	812	100.00%	Distribution not available
3020682	u-alb/krea	mg/mmol (mg/mmol)	488	879	0.00%
3020682	albumiininjakreatiininsuhde(virtsa)	mg/mmol (mg/mmol)	422	658	0.00%
3020682	albumiininjakreatiniininsuhde	— (—)	392	562	100.00%	Distribution not available
3020682	nu-albkre	mg/mmol (mg/mmol)	357	361	0.00%
3020682	u-albumiininjakreatiniininsuhde	mg/mmol (mg/mmol)	336	371	0.00%
3020682	albumiininjakreatiininsuhde(virtsa)	— (—)	301	430	100.00%	Distribution not available
3020682	u-albumiininjakreatiniininsuhde	— (—)	289	299	100.00%	Distribution not available
3020682	albumiininjakreatiniininsuhde	mg/mmol (mg/mmol)	278	301	0.00%
3020682	u-alb/kre	g/mol (mg/mmol)	67	142	0.00%
3020682	u-alb/kre,u-alb/krea	mg/mmol (mg/mmol)	67	148	0.00%
3020682	u-alb/kre,u-alb/krea	— (—)	46	99	100.00%	Distribution not available
3020682	u-albumiini/kreatiniini-suhdemikroalbuminuria	— (—)	30	35	100.00%	Distribution not available
3020682	u-alb/krea	g/mol (mg/mmol)	23	49	0.00%	Distribution not available
3020682	u-albumiini/kreatiniini-suhdemikroalbuminuria	mg/mmol (mg/mmol)	16	19	0.00%
3020682	u-albkres	— (—)	10	11	100.00%	Distribution not available
3020682	u-albkres	mg/mmol (mg/mmol)	9	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pre-eclampsia or poor fetal growth

4296

24206

2.07

320.68

4.8

3.7

24.21

7.10

mg/mmol

43.26

2982

14362

Hypothyroidism, strict autoimmune, 3 medication purchases required

15010

75072

1.50

320.60

4.1

3.8

9.93

9.60

mg/mmol

0.25

9130

47244

Oral corticosteroids

19557

88983

1.42

320.54

4.1

3.8

11.29

8.75

mg/mmol

7.80

12721

56253

Gonarthrosis,primary

17414

81739

1.47

318.97

3.8

7.78

9.11

mg/mmol

2.58

10901

51461

Other antidepressants

19197

74942

1.43

318.66

3.9

9.05

9.72

mg/mmol

0.89

12152

48482

Diverticular disease of intestine

14339

67860

1.53

317.02

4.0

3.7

9.86

8.12

mg/mmol

3.91

9141

42510

Hypertensive Renal Disease

901

2641

6.77

315.14

7.4

3.2

55.45

4.15

mg/mmol

30.00

760

1543

Examination and observation for other reasons

10381

41408

1.61

314.49

3.9

3.5

11.60

8.58

mg/mmol

5.79

6845

25970

Heart failure and coronary heart disease

8370

40531

1.77

311.18

4.5

3.8

22.73

8.11

mg/mmol

46.65

6050

25134

Nonalcoholic fatty liver disease

2089

9733

3.33

311.13

4.4

3.8

8.50

8.85

mg/mmol

0.12

1426

6139

Other disorders of skin and subcutaneous tissue

12949

84820

1.54

308.12

4.8

3.7

17.17

8.36

mg/mmol

33.94

8707

52649

Insulin, intermediate and long-acting

24474

63129

17.86

307.65

6.2

3.3

14.55

7.66

mg/mmol

36.94

18824

38658

Major coronary heart disease event

18143

70549

1.88

307.65

4.2

3.7

12.50

7.67

mg/mmol

17.07

11913

43331

Coronary revascularization (ANGIO or CABG)

17462

66426

2.00

307.65

4.2

3.7

12.09

7.46

mg/mmol

15.17

11486

40733

Cardiovascular diseases

10251

24951

2.60

307.65

4.4

3.4

13.43

6.58

mg/mmol

11.32

6905

15472

Infections, IBD-co-morbidities

2671

5076

4.88

307.65

5.3

2.0

21.24

7.64

mg/mmol

12.29

1874

2658

STROKE

10574

43035

2.01

307.65

4.0

3.3

13.28

5.14

mg/mmol

29.30

6800

25007

Cholelithiasis

16003

80319

1.55

307.65

4.0

3.8

8.75

8.74

mg/mmol

0.01

10167

49970

Disorders of choroid and retina

18628

81285

2.05

307.65

5.1

3.6

16.37

7.86

mg/mmol

53.79

12514

50747

Other disorders of glucose regulation and pancreatic internal secretion

1996

7955

4.29

307.65

6.4

3.8

18.55

9.08

mg/mmol

8.28

1504

5143

Type 1 diabetes, strict (exclude DM2)

4071

3257

86.55

307.65

6.6

2.6

7.49

18.06

mg/mmol

1.13

3115

1921

Insulin medication

25909

36848

21.21

307.65

6.1

2.4

14.64

10.91

mg/mmol

6.17

19857

20234

Gout, idiopatic and unspecified

5589

33068

2.39

307.65

5.3

3.8

22.42

8.93

mg/mmol

39.13

4129

21513

Unspecified kidney failure

2396

10886

3.63

307.65

6.6

3.5

39.94

5.07

mg/mmol

54.75

1976

6741

Any reimbursement code in KELA

11609

16276

4.56

307.65

4.4

2.1

11.16

8.67

mg/mmol

0.98

7942

8527

Insulin, fast-acting

15547

37589

20.62

307.65

6.7

3.3

15.71

8.29

mg/mmol

22.73

12134

23136

Hypothyroidism, levothyroxine purchases

4405

4688

6.76

307.65

4.5

2.1

10.40

16.90

mg/mmol

0.85

2925

2612

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

7486

37331

2.08

307.65

4.4

3.6

17.97

6.60

mg/mmol

42.83

5146

21150

All kidney diseases

23273

85609

2.38

307.65

5.6

3.3

24.22

3.93

mg/mmol

124.36

17239

51506

Other blood glucose lowering drugs, excl. Insulins

5188

12025

12.85

307.65

5.7

2.7

10.55

11.30

mg/mmol

0.39

3890

6587

Heart failure and antihypertensive medication

5596

8083

7.17

307.65

5.0

3.0

25.70

3.67

mg/mmol

57.71

4068

4296

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1878

3936

4.55

307.65

4.3

2.0

11.13

5.65

mg/mmol

3.96

1209

2021

Metabolic disorders

23477

73805

2.56

307.65

4.6

3.5

14.86

6.65

mg/mmol

21.40

15929

45429

Obesity and other hyperalimentation

15594

71047

2.99

307.65

4.5

3.8

11.74

8.90

mg/mmol

8.22

10748

44330

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6999

23274

2.21

307.65

4.2

3.1

10.77

3.89

mg/mmol

22.18

4432

13543

ILD medications: prednisolone, methylprednisolone, prednisone

20354

85184

1.47

307.65

4.7

3.6

13.77

8.36

mg/mmol

7.94

13536

53711

Type 2 diabetes

42829

41605

17.08

307.65

4.6

2.3

8.54

9.72

mg/mmol

2.79

29473

22094

Non-invasive ventilation

4792

10843

5.63

307.65

3.6

2.2

14.58

8.03

mg/mmol

7.89

3011

5670

Extracorporeal dialysis

1579

6271

5.65

307.65

12.1

3.8

78.21

7.92

mg/mmol

72.53

1499

4103

Pre-eclampsia

3419

16163

2.75

307.65

5.0

3.6

27.98

6.82

mg/mmol

45.07

2436

9379

ILD medications

20763

85621

1.43

307.65

4.7

3.6

13.91

8.38

mg/mmol

8.51

13846

54052

Medical observation and evaluation for suspected diseases and conditions

12597

41669

1.75

307.65

4.4

3.5

11.03

8.60

mg/mmol

4.53

8016

26151

Type1 diabetes, definitions combined, early onset

2717

2985

79.75

307.65

6.6

4.0

8.83

18.90

mg/mmol

1.15

2097

2064

Gout

6536

31991

2.51

307.65

5.4

3.8

22.27

8.79

mg/mmol

45.03

4820

20667

Obesity, other/unspecified

7345

34220

2.95

307.65

4.2

3.7

11.41

9.17

mg/mmol

2.57

5106

21402

Persons encountering health services for other counselling and medical advice, not elsewhere classified

20863

85772

1.45

307.65

4.2

3.7

12.20

8.63

mg/mmol

4.46

14730

53312

Influenza and pneumonia

18914

91516

1.44

307.65

4.4

3.8

16.72

7.49

mg/mmol

18.50

12750

57412

Erysipelas

15299

77877

1.78

307.65

4.4

3.7

16.31

6.64

mg/mmol

58.45

10467

48076

Other (not insulin) diabetes medications

43025

44681

17.24

307.65

4.5

2.4

7.00

10.21

mg/mmol

19.44

29420

24009

Nephropathy related operations

3194

13466

4.69

307.65

11.0

3.8

65.71

7.90

mg/mmol

36.58

2908

8727

Hypothyroidism, drug reimbursement

2520

3383

7.07

307.65

4.5

1.9

9.23

9.07

mg/mmol

0.04

1609

1726

Diseases of oesophagus, stomach and duodenum

20247

88320

1.53

307.65

4.1

3.8

11.54

8.68

mg/mmol

9.39

12898

56190

Gout, FINNGEN

6536

39559

2.23

307.65

5.4

3.8

22.27

8.48

mg/mmol

47.63

4820

25571

Other special examinations and investigations of persons without complaint or reported diagnosis

13347

41674

1.87

307.65

4.3

3.5

10.66

8.60

mg/mmol

3.72

9005

26153

Insulin, fast-acting or short human

15601

41281

16.39

307.65

6.7

3.5

15.74

8.85

mg/mmol

21.37

12175

25963

Pure hypercholesterolaemia

19026

65578

2.61

307.65

4.4

3.5

12.31

6.49

mg/mmol

33.30

12798

40055

Codeine

18546

67171

1.71

307.65

4.0

3.8

10.56

8.29

mg/mmol

6.18

11940

42618

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1416

2806

42.99

307.65

8.2

3.4

18.38

7.71

mg/mmol

7.06

1133

1778

Presence of cardiac and vascular implants and grafts

9438

46750

1.84

307.65

4.1

3.7

13.24

8.25

mg/mmol

14.60

6590

29705

Renal failure

13082

53432

3.65

307.65

7.0

3.5

36.13

4.90

mg/mmol

255.13

10709

32844

Chronic apical periodontitis

21055

89222

1.49

307.65

4.1

3.8

10.68

9.35

mg/mmol

2.29

13395

56880

Other retinal disorders

15518

69196

2.35

307.65

5.4

3.7

17.74

8.08

mg/mmol

53.34

10631

43154

Hypothyroidism (congenital or acquired)

4460

4694

6.84

307.65

4.5

2.1

10.49

16.88

mg/mmol

0.84

2973

2615

Diabetes medication

48041

46037

19.79

307.65

4.8

2.4

8.19

10.91

mg/mmol

5.77

33436

24936

Insulin, combination of fast acting with intermediate-acting or long-acting

25925

66984

11.26

307.65

6.1

3.3

14.65

7.74

mg/mmol

39.89

19869

40931

All-cause Heart Failure

11849

59833

1.66

307.65

4.6

3.8

23.20

6.88

mg/mmol

77.38

8454

36965

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

46362

41167

27.40

307.65

5.0

2.3

8.44

10.02

mg/mmol

1.91

32656

21801

Used for control exclusion in common control thyroid runs

21941

69071

1.87

307.65

4.8

3.4

12.44

8.31

mg/mmol

14.56

15030

43339

Periodontitis

19211

91330

1.61

307.65

4.2

3.8

11.15

8.68

mg/mmol

7.26

12377

57652

Disorders of gallbladder, biliary tract and pancreas

19784

87461

1.63

307.65

4.1

3.8

10.85

8.81

mg/mmol

5.40

12850

55048

Myocardial infarction

9784

47750

1.72

307.65

4.3

3.7

17.01

7.56

mg/mmol

34.87

6573

29594

Gout, strict definition

4196

23298

2.75

307.65

5.6

3.8

24.21

8.68

mg/mmol

36.98

3162

15230

Dipeptidyl peptidase 4 (DPP-4) inhibitors

23671

37887

25.13

307.65

5.3

2.7

10.67

10.41

mg/mmol

0.25

17243

20824

Sub-endpoint used in defining T1D endpoints

11083

29163

10.05

307.65

6.9

3.6

16.78

9.52

mg/mmol

14.12

8632

18666

Insulin, fast-acting (human)

5662

10906

22.78

307.65

7.4

3.2

17.25

8.51

mg/mmol

15.01

4409

6786

Neurological diseases, wide definition

4616

6470

4.25

307.65

4.1

2.1

11.82

10.72

mg/mmol

0.45

3115

3579

Nerve, nerve root and plexus disorders

22221

90045

1.77

307.65

4.3

3.8

10.28

9.11

mg/mmol

2.41

14608

56793

Autoimmune diseases

23556

73754

1.91

307.65

4.9

3.4

12.68

8.24

mg/mmol

18.14

16163

46141

Other heart diseases, wide

16987

71701

1.63

307.65

4.2

3.8

14.81

6.89

mg/mmol

33.15

10986

45078

Persons encountering health services in other circumstances, wide

21949

86016

1.44

307.65

4.2

3.7

12.61

8.64

mg/mmol

5.53

15125

53464

Diabetes, varying definitions

45445

42730

18.05

307.65

4.7

2.4

8.47

10.43

mg/mmol

2.92

31512

22910

Hypertension

21032

42301

4.15

307.65

4.6

3.1

13.64

4.19

mg/mmol

78.91

14519

24327

Hard cardiovascular diseases

17649

66890

1.90

307.65

4.2

3.7

12.97

7.23

mg/mmol

21.03

11561

41034

Endocrine, nutritional and metabolic diseases

21009

23913

6.45

307.65

4.4

2.2

10.80

8.67

mg/mmol

1.72

14586

12865

Heart failure, not strict

18558

69779

2.48

307.65

5.4

3.5

23.12

4.62

mg/mmol

151.03

13298

42036

Autoimmune diseases excluding thyroid diseases

22705

73511

2.01

307.65

5.1

3.4

13.34

8.23

mg/mmol

22.87

16036

45999

Angina pectoris

12456

53281

1.96

307.65

4.1

3.7

11.03

7.39

mg/mmol

11.01

8230

32618

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

19900

82914

1.83

307.65

4.9

3.6

15.32

7.89

mg/mmol

13.44

13186

52155

Diabetes mellitus

45793

42425

18.39

307.65

4.8

2.4

8.50

10.46

mg/mmol

2.84

31778

22680

Ischemic heart diseases

17870

67989

1.93

307.65

4.2

3.7

12.57

7.43

mg/mmol

18.11

11699

41738

Continuous positive airway pressure

4338

8701

6.67

307.65

4.7

2.2

15.97

7.02

mg/mmol

1.57

2852

4531

Diabetes mellitus in pregnancy

4853

12320

3.09

307.65

4.9

3.5

10.72

10.26

mg/mmol

0.21

3455

7545

Major coronary heart disease event excluding revascularizations

12266

56784

1.71

307.65

4.2

3.8

15.36

7.66

mg/mmol

32.27

8171

35016

Type 2 diabetes, strict (exclude DM1)

40016

41184

15.42

307.65

4.3

2.3

6.64

9.58

mg/mmol

15.78

27014

21809

Other bacterial diseases

19417

87937

1.73

307.65

4.7

3.7

19.20

6.79

mg/mmol

34.84

13516

54492

Other heart diseases

8634

24709

2.82

307.65

4.4

3.2

17.99

4.08

mg/mmol

47.46

5768

14609

Secondary hypertension

2282

5557

9.06

307.65

11.5

3.2

39.52

3.38

mg/mmol

59.63

1946

3207

Gestational [pregnancy-induced] hypertension

3587

18913

2.25

307.65

3.9

3.7

13.20

6.82

mg/mmol

10.48

2478

11098

Pregnancy hypertension

6731

33072

2.20

307.65

4.3

3.6

18.12

6.82

mg/mmol

38.35

4628

19001

Dyspnoea

17867

91259

1.67

307.65

4.1

3.8

13.40

8.67

mg/mmol

17.44

11437

57703

Autoimmune diseases excluding thyroid diseases, strict definition

22135

71658

2.02

307.65

5.1

3.4

13.35

8.29

mg/mmol

21.81

15684

44919

Glucagon-like peptide-1 (GLP-1) analogues

12036

20845

39.67

307.65

5.4

2.9

8.01

10.65

mg/mmol

5.54

9094

11696

Hypertension, essential

20428

41773

4.09

307.65

4.4

3.1

13.58

4.14

mg/mmol

79.51

13967

23962

Ischaemic heart disease, wide definition

16894

67651

1.91

307.65

4.2

3.7

12.84

7.37

mg/mmol

25.11

11031

41630

Pain in throat and chest

16563

65051

1.75

307.65

3.9

3.8

10.00

8.61

mg/mmol

1.79

10431

41623

Symptoms and signs involving the urinary system

14682

81775

1.55

307.65

4.3

3.8

13.27

8.68

mg/mmol

13.10

9752

51305

Cardiac arrhythmias

10443

21317

4.02

307.65

3.9

2.3

10.84

9.14

mg/mmol

1.93

6618

11189

Cholelithiasis, broad definition with cholecystitis

16664

81672

1.55

307.65

4.0

3.8

9.27

8.77

mg/mmol

0.63

10631

50905

Obesity

15540

70743

3.00

307.65

4.5

3.8

11.76

8.90

mg/mmol

8.29

10714

44148

Obesity related asthma

7300

42351

2.26

307.65

4.1

3.8

9.84

8.84

mg/mmol

0.88

4799

26547

Glomerular disorders in diseases classified elsewhere

3626

12619

8.10

307.65

11.3

3.6

65.98

6.18

mg/mmol

173.43

3321

8105

Episodal and paroxysmal disorders

20799

73707

1.60

307.65

4.0

3.8

9.57

9.71

mg/mmol

0.11

13450

46885

General examination and investigation of persons without complaint and reported diagnosis

11782

41627

1.65

307.65

3.9

3.5

10.54

8.60

mg/mmol

3.31

8071

26124

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

19766

91971

1.72

307.65

4.9

3.6

18.05

7.42

mg/mmol

70.23

13574

57305

Pain in limb

15373

69861

1.68

307.65

4.1

3.8

11.92

9.35

mg/mmol

5.10

9698

44627

Shoulder lesions

15139

65652

1.59

307.65

4.0

3.7

8.24

8.64

mg/mmol

0.44

9850

41488

Chronic kidney disease

9551

36853

5.31

307.65

8.1

3.5

42.19

5.16

mg/mmol

252.30

8159

22796

Care involving use of rehabilitation procedures

12049

79339

1.58

307.65

4.1

3.6

11.33

6.58

mg/mmol

17.32

8193

48860

Sulfonylureas

9996

23342

6.59

307.65

5.8

2.6

16.49

10.94

mg/mmol

11.95

7339

13059

Acute renal failure

5017

26084

2.86

307.65

6.1

3.5

31.61

5.07

mg/mmol

61.92

3976

16107

Depression medications

4212

4850

5.19

307.65

4.0

2.1

10.39

12.41

mg/mmol

1.05

2783

2724

Type 1 diabetes

10709

13382

36.29

307.65

7.0

2.4

16.68

12.41

mg/mmol

1.89

8362

7489

Hypertensive Heart Disease

5105

17883

3.14

307.65

4.6

3.1

20.73

3.93

mg/mmol

45.21

3588

10036

Hypothyroidism and >3 levothyroxin purchases

4405

4688

6.76

307.65

4.5

2.1

10.40

16.90

mg/mmol

0.85

2925

2612

Type 1 diabetes, wide definition, subgroup 1

9420

10333

68.12

307.65

7.1

2.4

15.60

13.37

mg/mmol

0.53

7388

5764

L04AD Calcineurin inhibitors

2626

10536

4.52

307.65

12.1

3.7

33.89

8.20

mg/mmol

6.27

2297

6759

Other nutritional deficiencies

15997

73421

2.84

307.65

4.5

3.8

11.73

8.93

mg/mmol

8.31

10991

45863

Dialysis, with operation codes

3402

13755

5.00

307.65

10.9

3.5

61.54

5.01

mg/mmol

128.93

3099

8690

Hypothyroidism, strict autoimmune

13528

61487

1.63

307.65

4.2

3.4

10.50

8.48

mg/mmol

3.03

8343

37903

Preparatory care for dialysis

1284

4511

10.03

307.65

13.1

3.9

69.86

8.15

mg/mmol

64.18

1247

2924

Atrial fibrillation and flutter

6215

18062

2.89

307.65

4.1

3.1

13.09

2.92

mg/mmol

34.78

4147

10279

Asthma, unspecified (mode)

10301

53962

1.64

307.65

3.8

3.7

10.08

6.82

mg/mmol

7.43

6504

33691

Gestational diabetes (for exclusion)

4763

16927

2.26

307.65

4.1

3.8

9.83

10.50

mg/mmol

0.37

3254

10525

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

12036

20845

39.67

307.65

5.4

2.9

8.01

10.65

mg/mmol

5.54

9094

11696

Obesity due to excess calories

11833

51987

3.41

307.65

4.6

3.8

12.39

8.88

mg/mmol

8.72

8145

32565

Sleep apnoea, including avohilmo

22674

82085

2.14

307.65

4.1

3.8

9.03

9.13

mg/mmol

0.09

14430

51713

Sleep apnoea

22044

81720

2.24

307.65

4.2

3.8

9.21

8.95

mg/mmol

0.28

14188

51259

Other soft tissue disorders, not elsewhere classified

17532

71000

1.63

307.65

4.1

3.8

11.39

9.48

mg/mmol

3.42

11163

45465

Condition for Implicit Sepsis (Organ dysfunction codes)

17059

83473

1.66

307.65

4.6

3.7

18.40

6.62

mg/mmol

67.00

11534

51854

Pre-eclampsia or eclampsia

3711

18012

2.67

307.65

4.9

3.6

26.56

6.91

mg/mmol

44.12

2617

10378

Diabetes, insulin treatment (Kela reimbursement)

48700

50653

22.51

307.65

4.9

2.5

8.58

9.74

mg/mmol

1.56

34314

27606

Renal tubulo-interstitial diseases

20496

84325

2.34

307.65

5.8

3.5

25.73

4.96

mg/mmol

206.28

15256

51077

Presence of other functional implants

11967

58241

1.68

307.65

4.7

3.6

13.22

7.84

mg/mmol

16.69

7400

35816

Hypertensive heart and/or renal disease

5965

19069

3.39

307.65

5.0

3.1

26.16

3.87

mg/mmol

70.43

4313

10696

Opioids

18003

67520

1.52

307.65

4.1

3.8

11.90

8.30

mg/mmol

12.40

11696

42882

Dialysis

1095

3552

8.25

307.65

14.2

3.6

62.27

4.83

mg/mmol

45.53

1055

2250

Percutaneous Coronary Intervention

17524

66405

2.02

307.65

4.2

3.7

12.04

7.47

mg/mmol

14.92

11519

40720

Kidney transplant status

1691

4665

16.06

307.65

15.1

3.6

42.23

5.62

mg/mmol

6.52

1633

2986

Transplanted organ and tissue status

2516

9755

5.05

307.65

11.5

3.6

34.45

8.18

mg/mmol

6.15

2216

6274

Acute tubulo-interstitial nephritis

11471

68497

1.65

307.65

4.8

3.5

16.82

5.22

mg/mmol

62.31

8038

41093

Sleep disorders (combined)

22448

80407

1.67

307.65

4.0

3.8

9.38

9.59

mg/mmol

0.22

14402

50967

Other bacterial diseases

20711

86923

1.76

307.65

4.6

3.7

17.78

6.75

mg/mmol

30.84

14277

53778

Statin medication

17844

27444

5.43

307.65

4.6

2.8

10.27

7.16

mg/mmol

9.17

12226

15871

Chronic periodontitis, including avohilmo

19145

91349

1.61

307.65

4.2

3.8

11.15

8.67

mg/mmol

7.30

12346

57659

Type 1 diabetes, wide definition

9609

11184

47.23

307.65

7.1

2.4

15.52

13.03

mg/mmol

0.68

7528

6269

Type 1 diabetes, definitions combined

4084

3281

83.03

307.65

6.5

2.6

7.48

17.96

mg/mmol

1.12

3125

1926

Glomerular diseases

5166

20371

5.23

307.65

10.9

3.6

66.62

5.93

mg/mmol

89.32

4656

13059

Cardiovascular diseases (excluding rheumatic etc)

12313

28410

3.11

307.65

4.5

3.3

13.37

6.06

mg/mmol

15.22

8350

17221

Implicit Sepsis

15243

79347

1.69

307.65

4.7

3.7

19.44

6.87

mg/mmol

75.35

10553

49141

Tramadol

16687

64683

1.87

307.65

4.2

3.7

12.85

7.87

mg/mmol

18.37

10833

40728

Type 1 diabetes, strict definition, subgroup 1

3445

1981

330.26

307.65

6.6

2.8

7.23

23.16

mg/mmol

1.08

2661

1223

Combinations of oral blood glucose lowering drugs

11242

22532

29.92

307.65

5.1

2.8

6.62

10.87

mg/mmol

14.86

8419

12777

Disorders of lens

14334

58988

1.83

307.65

4.7

3.6

14.70

7.43

mg/mmol

31.34

9541

36800

Other intervertebral disc disorders

15651

69778

1.50

307.65

3.7

3.9

7.55

9.51

mg/mmol

5.76

9967

44494

Parasetamol

14141

44833

1.81

307.65

4.1

3.7

11.94

7.93

mg/mmol

11.44

9405

28756

Persons encountering health services for examination and investigation

11993

41674

1.59

307.65

4.1

3.5

10.78

8.60

mg/mmol

3.49

7899

26153

Asthma, unspecified (mode), excluding more controls

9996

50333

1.71

307.65

3.9

3.7

10.16

6.04

mg/mmol

11.10

6310

31187

Diabetic maculopathy, excluding more controls

3905

6044

27.62

307.65

7.6

2.4

28.73

10.92

mg/mmol

24.87

3058

3328

Anaemias

4317

4512

8.55

307.65

5.7

2.1

25.80

16.55

mg/mmol

1.27

3142

2483

Type 2 diabetes, definitions combined, including avohilmo

39152

39670

14.78

307.65

4.2

2.3

6.53

9.84

mg/mmol

18.96

26306

21003

Thiazolidinediones

3891

8319

22.00

307.65

5.7

2.7

10.64

11.22

mg/mmol

0.23

2951

4631

Biguanides

42942

49838

16.74

307.65

4.4

2.9

6.77

11.16

mg/mmol

34.42

29427

28012

Emergency coronary revascularization (for ACS)

18917

72430

1.95

307.65

4.1

3.7

12.14

8.07

mg/mmol

13.19

12439

44564

Senile cataract

13070

54405

1.76

307.65

4.6

3.6

13.09

7.58

mg/mmol

19.42

8576

33786

Disorders of thyroid, IBD co-morbidities

2910

5532

4.65

307.65

4.3

2.0

8.80

9.69

mg/mmol

0.35

1846

2982

Hypertensive diseases (excluding secondary)

14224

24685

5.19

307.65

4.8

3.2

14.58

3.77

mg/mmol

68.35

9974

14440

Carpal tunnel syndrome

11895

71575

1.72

307.65

4.2

3.7

8.91

8.47

mg/mmol

0.41

7674

44006

Type 2 diabetes, wide definition

33541

39971

16.96

307.65

5.1

2.6

10.89

8.84

mg/mmol

6.12

23871

21450

Care involving dialysis

2379

8540

7.50

307.65

12.8

3.7

71.68

7.08

mg/mmol

108.78

2282

5438

Diseases of arteries, arterioles and capillaries (FINNGEN)

5292

14701

3.52

307.65

4.9

3.2

24.68

3.13

mg/mmol

60.40

3772

8368

Type 2 diabetes, definitions combined

39874

40871

15.48

307.65

4.3

2.3

6.65

9.55

mg/mmol

15.36

26926

21612

Glomerulonephritis

2288

10206

3.74

307.65

11.1

3.8

67.53

8.11

mg/mmol

21.05

2038

6611

Diseases of the eye and adnexa

13961

49454

1.55

307.65

4.4

3.5

12.05

8.04

mg/mmol

9.01

9400

31862

All chronic kidney diseases

16069

56510

3.86

307.65

7.1

3.4

35.34

3.48

mg/mmol

171.37

13189

33843

Special screening examination for other diseases and disorders

3236

10717

5.72

307.65

4.6

3.5

10.21

8.65

mg/mmol

0.93

2683

6724

Gout, unspecified

4541

26606

2.43

307.65

5.5

3.8

22.87

8.80

mg/mmol

36.10

3361

17276

Erysipelas

11388

70023

1.69

307.65

4.5

3.7

17.46

6.80

mg/mmol

50.69

7887

43573

Heart failure,strict

11226

51993

1.90

307.65

4.7

3.5

23.34

4.47

mg/mmol

107.03

8037

31390

Vocal cord dysfunction

1964

5855

3.72

307.65

3.9

2.1

8.82

7.12

mg/mmol

0.71

1224

2950

Disorders of lipoprotein metabolism and other lipidaemias

21787

68640

2.74

307.65

4.6

3.5

12.69

6.44

mg/mmol

42.67

14746

41999

Chronic periodontitis, complicated

10834

75273

1.70

307.65

4.6

3.8

12.55

8.42

mg/mmol

10.22

7163

47383

Gonarthrosis [arthrosis of knee](FG)

14920

63661

1.53

307.65

3.7

8.20

7.91

mg/mmol

0.24

9416

39748

Antihypertensive medication - note that there are other indications

11735

16322

4.90

307.65

4.4

3.3

14.42

6.82

mg/mmol

6.07

7985

9769

Coronary atherosclerosis

14345

57589

1.98

307.65

4.3

3.7

13.69

7.37

mg/mmol

26.56

9460

35330

Cerebrovascular diseases (FINNGEN)

5869

18833

2.80

307.65

4.1

3.1

16.41

3.16

mg/mmol

38.38

3873

10737

Persons encountering health services for specific procedures and health care

21044

86766

1.65

307.65

4.6

3.7

16.66

6.91

mg/mmol

73.69

14323

54074

Spondylopathies

15577

67057

1.57

307.65

3.8

9.08

9.20

mg/mmol

0.09

9935

42531

Heart failure, strict

12045

60610

1.67

307.65

4.6

3.8

23.31

6.88

mg/mmol

79.67

8609

37460

Finngen Rheumatological endpoints

17566

72558

1.52

307.65

4.1

3.8

11.00

8.98

mg/mmol

3.98

11480

46196

Codeine or tramadol medication

22717

85536

1.65

307.65

4.0

3.8

10.38

9.21

mg/mmol

2.43

14616

54382

Neurological diseases

15274

53721

1.57

307.65

4.0

3.8

10.38

9.40

mg/mmol

0.97

10009

34121

Abnormalities of breathing

17791

65882

1.81

307.65

4.0

3.8

11.91

8.78

mg/mmol

7.56

11456

42257

Symptoms and signs involving the circulatory and respiratory systems

17956

66009

1.49

307.65

4.0

3.8

11.03

8.79

mg/mmol

4.53

11611

42350

Atrial fibrillation and flutter with reimbursement

5624

15007

3.33

307.65

4.0

3.1

10.47

2.82

mg/mmol

28.25

3755

8399

Complications of surgical and medical care, not elsewhere classified

18615

94529

1.50

307.65

4.1

3.8

14.15

8.36

mg/mmol

28.99

12238

59583

Polyarthropathies

13447

56516

1.81

307.65

4.7

3.8

17.17

8.87

mg/mmol

31.30

9291

36101

Other cataract

8810

44649

1.79

307.65

4.8

3.6

16.06

7.75

mg/mmol

20.99

5739

27661

Elevated blood glucose level

1931

8419

3.87

307.65

5.0

3.8

16.31

8.55

mg/mmol

5.52

1403

5373

Type 1 diabetes, strict definition

3556

2145

222.65

307.65

6.6

2.8

7.31

21.76

mg/mmol

1.04

2741

1315

Hyperlipidaemia, other/unspecified

9179

47854

2.44

307.65

4.9

3.6

14.61

6.73

mg/mmol

29.58

6255

29346

Hypertensive diseases

21032

42312

4.15

307.65

4.6

3.1

13.63

4.19

mg/mmol

78.75

14521

24335

Paroxysmal tachycardia

3420

15092

2.25

307.38

3.9

3.2

8.32

3.90

mg/mmol

9.11

2151

8644

Other disorders of fluid, electrolyte and acid-base balance

5947

36137

1.92

307.18

4.7

3.5

25.94

6.84

mg/mmol

9.80

4048

21900

All pneumoniae

18107

92620

1.43

307.12

4.4

3.8

17.18

7.56

mg/mmol

18.57

12244

58082

Other diseases of intestines

18724

81365

1.42

306.94

4.0

3.8

10.56

9.15

mg/mmol

2.40

11971

52164

Bleeding

15723

84619

1.48

304.32

4.5

3.8

16.80

8.05

mg/mmol

42.19

10593

52970

Spinal stenosis

10343

56062

1.64

303.43

3.9

3.8

9.63

8.97

mg/mmol

0.59

6574

35041

Diseases of pulp and periapical tissues, including avohilmo

19088

75816

1.42

301.82

4.0

3.8

10.14

9.53

mg/mmol

0.66

12186

48348

Symptoms and signs involving cognition, perception, emotional state and behaviour

17653

92146

1.43

301.74

3.9

9.39

9.24

mg/mmol

0.15

11056

58736

Disorders resulting from impaired renal tubular function

1017

3560

8.48

300.52

12.1

3.8

51.73

8.20

mg/mmol

32.30

942

2268

Pneumonias (Asthma/COPD co-morbidities)

17977

92583

1.42

300.23

4.4

3.7

17.00

7.55

mg/mmol

18.03

12173

58022

IgA nephropathy (IgA glomerulonephritis)

744

2139

15.61

300.21

11.7

3.9

41.95

9.44

mg/mmol

24.07

702

1410

Other CVD (FINNGEN)

2125

7431

2.98

300.19

4.5

3.2

17.23

3.33

mg/mmol

13.41

1383

4105

Soft tissue disorders

18234

71430

1.42

299.75

4.0

3.8

10.53

9.53

mg/mmol

1.33

11849

45779

Diseases of arteries, arterioles and capillaries

13033

71474

1.54

298.37

4.7

3.7

20.99

7.40

mg/mmol

77.18

9173

44574

Gonarthrosis

12569

52189

1.54

294.15

3.7

8.29

8.07

mg/mmol

0.16

7973

32965

Hypoglycaemia, other or unspecified

1510

6223

3.96

292.85

6.2

3.8

19.03

9.38

mg/mmol

6.29

1136

4033

Peripheral artery disease

8887

49826

1.70

290.13

5.1

3.7

24.59

7.78

mg/mmol

69.87

6527

31331

Viral hepatitis, IBD co-morbidity

704

1660

5.35

289.41

4.1

2.1

21.59

10.58

mg/mmol

2.14

450

924

Inflammatory bowel disease treatment related agents

20603

90036

1.38

287.58

4.2

3.8

12.42

8.86

mg/mmol

3.89

13585

57070

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1257

4556

3.83

286.58

4.6

3.5

13.15

5.87

mg/mmol

4.53

866

2738

Dorsalgia

17664

72372

1.42

283.95

3.8

3.9

9.30

9.79

mg/mmol

0.59

11283

46504

Myocardial infarction, strict

9019

45276

1.68

282.50

4.2

3.8

16.77

7.73

mg/mmol

29.37

6047

28176

Hypothyroidism, other/unspecified

15796

78999

1.44

280.60

4.2

3.8

10.13

9.60

mg/mmol

0.49

9731

50173

Hypothyreosis and Thyroxine purchase for inclusion criteria

16319

81821

1.43

279.80

4.2

3.8

10.00

9.62

mg/mmol

0.33

10021

51881

L04AA Selective immunosuppressants

4087

24332

2.11

278.83

9.0

3.7

26.27

8.63

mg/mmol

5.94

3249

15215

Ulcer of lower limb, not elsewhere classified

3083

17326

2.55

277.99

6.0

3.7

34.38

9.01

mg/mmol

36.82

2316

10977

Bacterial Sepsis

9138

55481

1.64

277.08

5.0

3.7

24.64

7.09

mg/mmol

74.41

6662

34622

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

17580

92805

1.41

275.93

4.4

3.8

17.15

7.62

mg/mmol

17.63

11918

58175

Lower back pain or/and sciatica

18913

96446

1.39

275.47

3.8

3.9

8.85

9.55

mg/mmol

1.13

11895

61558

Asthma, excluding more controls

13683

52838

1.48

274.19

3.8

3.7

9.35

6.25

mg/mmol

9.31

8782

33029

Intracranial trauma

9446

46382

1.57

273.02

3.9

3.8

10.35

8.85

mg/mmol

1.48

6050

29352

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

16164

74769

1.43

272.68

4.4

3.7

17.15

7.38

mg/mmol

15.92

10889

46601

16164

74769

1.43

272.68

4.4

3.7

17.15

7.38

mg/mmol

15.92

10889

46601

Disorder of lipoprotein metabolism, unspecified

2839

15590

2.58

270.63

4.9

3.6

16.60

7.01

mg/mmol

10.67

1986

9589

Other disorders involving the immune mechanism, not elsewhere classified

841

2730

8.00

270.31

11.2

3.9

40.71

15.87

mg/mmol

3.55

779

1795

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

802

2540

8.76

269.67

11.4

3.9

40.92

16.46

mg/mmol

3.13

747

1676

Genitourinary diseases

10480

37214

1.55

265.37

4.6

3.4

16.76

3.74

mg/mmol

14.27

7319

23749

Disorders of the thyroid gland

16825

84695

1.41

264.48

4.1

3.8

10.24

9.62

mg/mmol

0.64

10542

54153

Low back pain

13274

71331

1.47

263.80

3.8

3.9

9.13

9.74

mg/mmol

0.68

8313

45724

Codes for special purposes

9137

65017

1.59

263.72

4.6

3.8

14.69

9.41

mg/mmol

12.22

6515

41355

Provisional assignment of new diseases of uncertain etiology

9124

64924

1.59

263.34

4.6

3.8

14.68

9.42

mg/mmol

12.15

6507

41295

Other diseases of liver

3449

20075

2.24

261.23

4.5

3.8

11.08

8.73

mg/mmol

1.61

2322

12633

Other disorders of urethra and urinary system

12404

66554

1.49

261.19

4.4

3.7

15.28

8.44

mg/mmol

25.68

8027

41246

Complications of procedures, not elsewhere classified

14597

92413

1.44

260.98

4.1

3.8

14.20

8.35

mg/mmol

24.07

9650

58064

Infections of the skin and subcutaneous tissue

10007

71764

1.55

260.64

4.6

3.8

18.53

8.78

mg/mmol

7.25

6850

46420

Charcot foot

544

1341

16.75

260.35

8.8

3.3

39.20

4.25

mg/mmol

13.05

452

806

Dental operations

11858

44553

1.52

259.46

3.9

3.7

11.17

9.44

mg/mmol

0.57

7501

28483

Diseases of the skin and subcutaneous tissue

18276

71208

1.39

258.44

4.3

3.6

12.39

7.85

mg/mmol

17.92

11939

45039

Implicit bacterial Sepsis

8075

50551

1.67

256.86

5.1

3.7

25.12

7.13

mg/mmol

70.67

5916

31507

Other dialysis

846

2925

8.65

254.96

14.9

3.9

62.57

9.35

mg/mmol

33.65

818

1921

Pneumonia, organism unspecified

16243

88270

1.41

254.20

4.4

3.8

17.60

7.33

mg/mmol

17.86

11033

55279

Cholecystectomy

12779

83341

1.47

253.60

3.9

3.8

8.27

9.05

mg/mmol

1.13

8118

51599

General symptoms and signs

19269

75776

1.37

251.22

4.1

3.8

13.13

7.54

mg/mmol

26.71

12711

47775

Rotator cuff syndrome

11693

62563

1.51

251.01

3.8

3.7

7.87

8.52

mg/mmol

0.73

7537

39413

Caries of dentine, including avohilmo

14653

56805

1.44

250.77

3.9

3.7

9.70

9.81

mg/mmol

0.07

9264

36249

Gingivitis and periodontal diseases

18731

75922

1.38

249.00

4.1

3.7

10.71

8.87

mg/mmol

3.69

11924

48428

Other and unspecified iron deficiency

6018

40354

1.76

245.68

4.7

3.7

16.01

9.53

mg/mmol

9.43

4157

24988

Oedema, not elsewhere classified

6202

41406

1.75

245.45

4.5

3.7

19.27

7.41

mg/mmol

28.43

4105

25504

Dental caries, including avohilmo

13875

53680

1.45

243.76

3.9

3.7

9.61

9.78

mg/mmol

0.11

8783

34160

Dental caries

4517

27269

1.89

239.93

5.7

3.7

25.00

8.82

mg/mmol

29.18

3315

17853

Benign neoplasm of colon, rectum, anus and anal canal

12148

80396

1.49

239.73

4.2

3.8

11.65

8.64

mg/mmol

8.11

8116

49881

Asthma

14246

56817

1.43

239.45

3.8

3.7

9.45

6.98

mg/mmol

6.24

9141

35780

Diseases of liver

6366

43672

1.73

238.57

4.4

3.8

13.67

8.66

mg/mmol

7.99

4260

27691

Iron deficiency anaemia

7587

52706

1.64

238.54

4.6

3.7

16.83

9.38

mg/mmol

15.39

5201

32696

Caries of dentine

4049

24150

1.96

238.44

5.7

3.7

25.88

8.71

mg/mmol

26.57

2982

15835

Vitreous haemorrhage

2132

11175

2.83

236.47

7.0

3.8

32.76

9.57

mg/mmol

22.41

1632

7162

Chronic nephritic syndrome

984

3771

5.58

236.42

12.7

3.6

47.95

6.51

mg/mmol

36.66

896

2404

Arthrosis

13183

54786

1.45

234.01

3.7

8.29

8.20

mg/mmol

0.08

8446

34783

Missing teeth due to accident, extraction or parodontitis

11149

79532

1.51

233.14

4.2

3.8

9.17

8.99

mg/mmol

0.14

6760

49911

Aplastic and other anaemias

8581

58069

1.59

231.91

5.2

3.7

23.72

8.61

mg/mmol

44.85

6212

36237

Explicit Sepsis

8127

54447

1.60

230.84

5.1

3.7

26.18

7.27

mg/mmol

18.28

5951

33953

Diarrhoea and gastroenteritis of presumed infectious origin

11972

81434

1.45

230.50

4.8

3.7

17.07

8.57

mg/mmol

7.83

8260

51791

Diseases of pulp and periapical tissues and dental caries

12436

47771

1.46

230.40

3.9

3.7

9.69

9.75

mg/mmol

0.04

7885

30464

Artrosis, including avohilmo

14876

62770

1.41

230.00

3.7

3.9

7.68

9.99

mg/mmol

7.45

9534

40414

Nutritional anaemias

8840

62024

1.56

229.80

4.6

3.7

16.03

9.15

mg/mmol

16.45

6000

38555

Septicaemia

7895

52923

1.61

228.19

5.1

3.7

26.70

7.28

mg/mmol

18.11

5765

32901

Gastro-oesophageal reflux disease

12347

81364

1.45

227.26

4.0

3.8

9.68

8.46

mg/mmol

1.67

7422

51326

First line medication for Crohn's disease

19496

84049

1.34

226.31

4.6

3.6

13.93

8.29

mg/mmol

7.91

12986

53100

Other dorsopathies, not elsewhere classified

17594

72457

1.36

225.97

3.8

3.9

8.81

9.81

mg/mmol

1.71

11257

46565

Complications of medical and surgical care

13074

92708

1.43

225.40

4.1

3.8

14.98

8.68

mg/mmol

20.99

8572

58027

Asthma (mode)

13965

57269

1.42

224.67

3.8

3.7

8.82

7.03

mg/mmol

3.88

8950

36108

Personality disorders, excluding more controls

3876

23566

1.89

223.55

3.9

10.07

9.01

mg/mmol

0.56

2427

15397

Other disorders of ear

16635

86110

1.38

222.98

4.0

3.8

8.45

9.57

mg/mmol

1.85

10219

54778

Covid-19 confirmed case

6499

45240

1.67

221.27

4.7

3.8

18.42

9.79

mg/mmol

17.03

4450

28720

Unspecified mental disorder

6562

45371

1.64

219.61

3.8

3.9

8.90

9.42

mg/mmol

0.27

4051

29303

Benign neoplasms

16963

73622

1.36

218.54

4.1

3.8

12.06

9.26

mg/mmol

1.96

11280

47581

Other diseases of hard tissues of teeth

11057

42564

1.48

218.28

3.9

3.7

11.21

9.10

mg/mmol

0.65

6910

27352

Other and unspecified anaemias

7893

54498

1.60

216.83

4.9

3.7

21.74

8.70

mg/mmol

34.19

5661

34035

Nephrotic syndrome

777

2723

6.32

216.71

14.3

3.6

115.00

5.88

mg/mmol

10.17

730

1763

Concussion

7947

45987

1.55

216.32

3.8

9.18

8.82

mg/mmol

0.21

5076

29092

Kela-code for severe mental illness

5970

40707

1.67

216.26

3.8

3.9

8.34

9.48

mg/mmol

0.74

3675

26283

Certain infectious and parasitic diseases

17402

68819

1.36

215.38

4.3

3.6

14.44

6.51

mg/mmol

12.68

11632

42526

Other arrhythmias

11068

62904

1.46

215.01

3.7

8.52

6.35

mg/mmol

5.22

6560

39009

Other anaemias

7943

54866

1.59

214.12

4.9

3.7

21.64

8.68

mg/mmol

34.22

5697

34243

Dizziness and giddiness

13493

83186

1.41

212.92

3.8

9.20

9.16

mg/mmol

0.03

8382

52492

Isolated proteinuria

741

2580

6.89

212.38

9.2

3.9

64.05

9.31

mg/mmol

34.37

684

1689

ILD medications: immunosuppressive drugs

11005

77430

1.45

212.27

6.0

3.6

16.99

7.87

mg/mmol

8.21

7813

48456

Unspecified haematuria

8053

48653

1.59

210.58

4.4

3.8

14.71

8.84

mg/mmol

15.87

5674

31289

Other septicaemia

7027

48189

1.63

210.20

5.2

3.7

27.41

7.39

mg/mmol

15.88

5152

29963

Factors influencing health status and contact with health services

5617

18468

1.70

206.89

4.1

3.3

10.58

5.57

mg/mmol

9.58

3723

11679

Familial hypercholesterolemia

3028

18252

2.17

206.43

4.6

3.6

12.09

7.11

mg/mmol

5.92

2071

11228

Asthma (only as main-diagnosis), excluding more controls

12148

52838

1.43

205.95

3.8

3.7

9.11

6.25

mg/mmol

7.85

7720

33029

Asthma (diagnoses ohter than nonallergic)

14880

97420

1.37

204.69

3.8

3.9

9.48

9.64

mg/mmol

0.12

9427

61871

Chronic lower respiratory diseases

20978

90875

1.31

204.51

3.8

3.9

10.66

9.28

mg/mmol

2.33

13462

57977

Unstable angina pectoris

7011

39604

1.64

204.44

4.0

3.8

13.77

8.10

mg/mmol

8.97

4697

24615

Cystic kidney disease

789

2889

5.87

204.29

9.3

3.9

16.85

8.83

mg/mmol

4.60

695

1847

Conductive and sensorineural hearing loss

14717

78459

1.39

204.25

4.0

3.8

7.92

9.47

mg/mmol

3.38

9069

49669

Other disorders of kidney and ureter

2590

15107

2.36

203.79

7.8

3.8

34.33

8.95

mg/mmol

35.76

2064

9593

Polycystic kidney disease

695

2404

7.30

203.26

9.6

3.8

17.49

8.93

mg/mmol

4.58

625

1532

Bacterial infection, other or unspecified

10505

67536

1.47

202.46

4.8

3.7

21.19

6.98

mg/mmol

70.06

7426

41572

Diseases of oral cavity, salivary glands and jaws

11081

42818

1.46

202.39

3.9

3.7

11.54

9.13

mg/mmol

0.83

7044

27514

Other specific joint derangements/joint disorders

11923

58714

1.42

201.86

4.0

3.8

9.80

9.28

mg/mmol

0.40

7499

37830

Fever of other and unknown origin

9797

65341

1.47

201.26

4.6

3.8

18.06

7.52

mg/mmol

8.12

6766

41051

Gonarthrosis, primary, with knee surgery

10946

67118

1.48

200.38

3.7

3.8

6.78

9.17

mg/mmol

7.10

6645

41701

Myocardial infarction, without ST-elevation

7704

51569

1.59

198.98

4.3

3.8

19.04

8.82

mg/mmol

30.33

5227

32980

Maternal care for other conditions predominantly related to pregnancy

2391

12658

2.10

198.79

4.2

3.6

8.63

10.19

mg/mmol

0.84

1576

7638

Sensorineural hearing loss

14144

75844

1.40

198.56

4.0

3.8

7.91

9.49

mg/mmol

3.34

8747

47904

Use of hypnotics and sedatives

18983

88296

1.33

198.54

3.9

10.35

9.08

mg/mmol

2.21

11870

56593

Mood disorders, excluding more controls

16626

79214

1.35

198.38

4.0

3.9

10.22

8.65

mg/mmol

2.62

10503

50359

Implicit viral Sepsis

3722

23729

1.92

195.09

5.5

3.7

23.26

7.39

mg/mmol

26.23

2693

14834

Viral Sepsis

3727

23773

1.92

194.92

5.5

3.7

23.26

7.39

mg/mmol

26.30

2697

14866

Any death

7569

72834

0.66

194.66

3.7

3.9

28.77

6.62

mg/mmol

71.65

5047

45624

GASTRO-related operations

13437

52040

1.38

192.82

4.2

3.6

13.62

6.71

mg/mmol

6.09

8691

33304

Any gastric operation

13437

52040

1.38

192.82

4.2

3.6

13.62

6.71

mg/mmol

6.09

8691

33304

Primary gonarthrosis, bilateral

9635

62946

1.49

190.12

3.8

7.67

9.03

mg/mmol

1.44

5853

38962

Lumbar disc prolapse

11313

66905

1.42

188.80

3.8

3.9

7.73

9.33

mg/mmol

2.98

7255

42536

Constipation

15795

87725

1.35

188.63

4.0

3.8

11.14

9.08

mg/mmol

3.43

9564

55685

Benign neoplasm: Colon

10170

74965

1.47

187.06

4.3

3.8

11.83

8.76

mg/mmol

7.17

6830

46583

Asthma, including avohilmo

20472

94282

1.30

186.70

3.7

3.9

9.02

9.81

mg/mmol

1.10

12981

60365

Abnormal findings on examination of blood, without diagnosis

8615

59588

1.51

184.81

4.3

3.9

13.79

9.79

mg/mmol

6.82

6061

38711

Chronic pancreatitis

2436

14334

2.30

184.25

5.0

3.8

17.60

9.10

mg/mmol

6.23

1695

9304

Coronary artery bypass grafting

5108

26304

1.75

183.07

4.4

3.8

14.52

8.33

mg/mmol

11.60

3584

16823

Other maternal disorders predominantly related to pregnancy

7683

34724

1.51

182.94

4.2

3.6

9.52

8.06

mg/mmol

1.56

4936

19714

Arthropathies in other diseases classified elsewhere

862

3478

4.63

182.68

7.4

3.7

32.10

8.49

mg/mmol

11.00

653

2211

Spondylosis

9933

61990

1.46

181.85

3.7

3.8

8.24

8.88

mg/mmol

0.58

6174

39023

Trigger finger

2658

15867

2.11

180.65

5.1

3.7

11.89

8.76

mg/mmol

1.95

1791

9801

Haemorrhage from respiratory passages

6363

41122

1.60

180.23

4.2

3.8

14.20

8.85

mg/mmol

8.12

4235

26133

Artificial joint operation, meniscal resection

16696

88069

1.34

180.05

3.7

3.8

7.29

9.35

mg/mmol

6.59

10400

55816

Congenital malformations of the urinary system

1170

5313

3.25

179.65

8.1

3.9

18.33

9.21

mg/mmol

7.05

967

3417

Schizophrenia or delusion, excluding more controls

4810

32210

1.67

178.39

3.8

3.9

9.36

8.50

mg/mmol

0.39

2962

20807

Selective serotonin reuptake inhibitors

17736

75058

1.32

177.68

3.9

8.89

9.70

mg/mmol

1.09

11070

48581

Fall on same level

19708

88328

1.29

176.15

4.0

3.9

11.79

9.06

mg/mmol

6.77

12566

56663

Coxarthrosis

9421

47243

1.47

176.07

3.8

3.7

8.92

8.10

mg/mmol

0.82

5998

29675

Congenital malformations of the urinary system

1100

4909

3.33

175.73

8.4

3.9

18.52

9.24

mg/mmol

6.80

924

3150

Malaise and fatigue

9140

55709

1.46

175.23

4.0

3.8

14.80

7.52

mg/mmol

20.30

5926

34618

Sciatica+with lumbago

8861

61619

1.46

175.16

3.8

3.9

7.60

9.21

mg/mmol

3.04

5676

38837

Disorders of eyelid, lacrimal system and orbit

14873

90904

1.34

174.48

3.9

3.8

9.79

9.34

mg/mmol

0.38

9162

57439

Cutaneous abscess, furuncle and carbuncle

4270

28517

1.74

174.32

4.8

3.9

19.29

8.60

mg/mmol

16.24

2976

18521

Bacterial infection, other or unspecified

9648

64308

1.45

174.25

4.8

3.7

22.17

6.97

mg/mmol

69.14

6816

39661

Atherosclerosis, excluding cerebral and coronary sclerosis

7866

46740

1.54

173.57

4.9

3.7

25.24

7.92

mg/mmol

62.66

5728

29394

Polycystic ovarian syndrome, consortium definition

10316

46547

1.42

171.87

3.9

3.6

8.41

8.78

mg/mmol

0.30

6028

27147

Disease of hard tissues of teeth, NOS

10331

41318

1.44

171.65

3.9

3.7

7.78

8.96

mg/mmol

1.53

6302

26523

Benzodiazepine use

17361

97700

1.31

170.31

3.8

3.9

9.93

9.35

mg/mmol

0.63

10413

62842

Non-selective monoamine reuptake inhibitors

6746

47615

1.55

169.30

3.8

8.06

8.35

mg/mmol

0.16

4219

29328

Disorders of adult personality and behaviour

4063

26743

1.71

168.73

3.8

4.0

9.42

10.05

mg/mmol

0.31

2521

17528

Asthma (only as main-diagnosis)

12504

56817

1.37

168.35

3.8

3.7

9.11

6.98

mg/mmol

4.68

7924

35780

Valvular heart disease excluding rheumatic fever

8496

46373

1.49

167.97

4.2

3.7

15.27

6.02

mg/mmol

34.17

5493

28669

Non-rheumatic valve diseases

8476

46232

1.49

167.74

4.2

3.7

15.15

6.00

mg/mmol

33.62

5480

28571

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6149

21416

1.56

167.69

4.0

3.6

10.94

5.75

mg/mmol

10.04

3997

13651

Heart failure and bmi 25plus

7280

36923

1.59

166.88

4.7

3.9

22.37

6.73

mg/mmol

48.34

5095

22885

Disorders of synovium and tendon

9012

60052

1.44

166.84

4.3

3.8

10.50

8.92

mg/mmol

1.58

5796

37717

Mixed hyperlipidaemia

917

3975

4.03

166.59

5.4

3.6

21.30

6.35

mg/mmol

6.50

661

2506

Conduction disorders

5440

31199

1.64

165.85

4.2

3.7

12.89

6.18

mg/mmol

14.93

3550

19383

Hyperkalaemia

1178

5605

3.17

165.81

6.3

3.6

38.22

6.66

mg/mmol

22.66

935

3519

Abnormal findings on examination of urine, without diagnosis

952

4190

3.82

165.48

8.1

3.9

54.06

8.96

mg/mmol

34.13

842

2730

Persons encountering health services in other circumstances

6485

46795

1.53

165.47

4.4

3.8

12.17

8.66

mg/mmol

5.58

4083

28969

Disorders of other endocrine glands

6959

50321

1.51

164.73

4.8

3.8

18.00

8.92

mg/mmol

3.46

4650

31374

Mood disorders

17398

92228

1.30

164.51

4.0

3.8

10.33

9.12

mg/mmol

1.73

11009

58582

Coxarthrosis [arthrosis of hip](FG)

10176

55619

1.43

163.79

3.8

3.7

8.84

7.97

mg/mmol

0.97

6440

34424

Non-ischemic cardiomyopathy

5517

31709

1.64

162.89

4.4

3.7

20.59

6.68

mg/mmol

29.06

3814

19200

Other arthrosis

9500

50581

1.44

162.57

3.7

7.47

8.01

mg/mmol

0.57

5912

31915

Mood [affective] disorders

17340

92165

1.30

162.35

4.0

3.8

10.33

9.09

mg/mmol

1.79

10963

58541

Abdominal and pelvic pain

17819

73222

1.30

162.25

4.0

3.8

11.34

8.92

mg/mmol

4.41

11502

46797

Other diseases of urinary system

17347

79821

1.30

161.91

4.3

3.8

13.69

8.42

mg/mmol

24.78

11473

50488

Asthma/COPD (KELA code 203)

16238

90761

1.31

161.83

3.7

3.9

9.00

9.28

mg/mmol

0.24

10246

57890

Personality disorders

3876

25538

1.72

161.01

3.9

10.07

10.05

mg/mmol

0.01

2427

16676

Pain (limb, back, neck, head abdominally)

12994

51405

1.35

159.87

3.9

3.8

10.75

8.87

mg/mmol

2.39

8464

33172

Hernia of abdominal wall, postoperative

3538

23368

1.83

159.16

4.5

3.6

12.91

6.14

mg/mmol

9.82

2350

14929

Certain disorders involving the immune mechanism

3262

21198

1.87

157.61

6.2

3.8

21.76

9.81

mg/mmol

13.68

2371

13519

Other and unspecified polyneuropathies, also in other diseases

3558

23860

1.85

156.29

5.3

3.8

20.81

9.45

mg/mmol

13.38

2510

15326

Hernia of abdominal wall

8027

61284

1.47

156.18

4.3

3.8

10.63

9.21

mg/mmol

1.28

5366

39303

Nausea and vomiting

4550

30752

1.65

155.77

4.7

3.7

18.37

9.30

mg/mmol

10.18

3125

19018

Dorsopathies

17395

72575

1.29

151.60

3.8

3.9

8.98

10.05

mg/mmol

1.51

11145

46665

Acute pancreatitis

3500

23335

1.80

150.95

4.4

3.8

15.89

9.12

mg/mmol

6.81

2323

14987

Arthropathies

14749

60222

1.31

150.48

4.1

3.8

11.02

9.33

mg/mmol

2.47

9668

38898

Bipolar affective disorders

2736

16951

1.86

148.33

3.8

3.9

9.39

9.43

mg/mmol

0.01

1709

11073

Gastrointestinal diseases

9547

36503

1.40

147.71

4.0

3.6

12.64

7.60

mg/mmol

2.10

6218

23174

Idiopathic gout

1879

11067

2.40

147.39

5.2

3.8

23.02

8.62

mg/mmol

13.40

1400

7266

Pain in joint

10000

49619

1.39

146.66

3.9

3.8

9.77

8.82

mg/mmol

0.79

6274

31972

Pacemaker

5981

42588

1.56

144.91

4.0

3.8

12.08

9.86

mg/mmol

2.71

3985

27040

Depression

15816

88156

1.29

144.51

4.0

3.8

10.27

8.97

mg/mmol

1.87

10035

55880

Symptoms and signs involving the digestive system and abdomen

17672

73222

1.28

144.30

4.1

3.8

11.20

8.92

mg/mmol

4.72

11467

46797

Intestinal infectious diseases

15709

98176

1.29

143.87

4.7

3.7

16.55

8.42

mg/mmol

11.14

10674

61990

Drug-induced hypoglycaemia without coma

435

1387

8.11

143.59

6.8

3.8

22.17

11.07

mg/mmol

2.46

333

902

AV-block

3376

19730

1.80

142.75

4.2

3.8

14.23

6.31

mg/mmol

12.31

2275

12364

Schizophrenia or delusion

4810

34007

1.58

142.68

3.8

3.9

9.36

9.53

mg/mmol

0.06

2962

22016

Depression or dysthymia

12156

53615

1.35

141.96

4.0

3.9

9.90

8.98

mg/mmol

1.02

7674

34480

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10487

82462

1.37

141.88

4.1

3.8

15.40

8.44

mg/mmol

21.05

6878

51564

Diseases of the musculoskeletal system and connective tissue

8600

32607

1.41

141.04

4.1

3.7

11.12

9.21

mg/mmol

1.58

5706

21145

Autoimmune diseases related-to ILD

14154

99139

1.30

140.75

4.5

3.8

11.59

9.04

mg/mmol

6.05

9356

62782

Schizophrenia, schizotypal and delusional disorders

4821

34241

1.58

139.39

3.8

3.9

9.43

9.51

mg/mmol

0.03

2970

22156

Specific personality disorders

3272

21492

1.72

137.49

3.8

4.0

9.00

10.25

mg/mmol

0.71

2027

14099

Peripheral arterial reconstruction

3181

21415

1.85

137.48

5.1

3.8

29.40

9.23

mg/mmol

27.08

2321

13745

Asthma, hospital admission 2, infections

9414

72422

1.38

137.32

3.9

3.8

11.60

9.88

mg/mmol

1.72

6156

45776

Asthma-related infections

9414

72422

1.38

137.32

3.9

3.8

11.60

9.88

mg/mmol

1.72

6156

45776

Diseases of the ear and mastoid process

19602

82539

1.26

137.04

4.1

3.8

10.52

9.62

mg/mmol

0.43

12330

53088

Extreme obesity with alveolar hypoventilation

865

3983

3.62

136.98

4.4

3.6

12.60

7.66

mg/mmol

2.04

553

2453

Redundant prepuce, phimosis and paraphimosis

3443

22891

1.73

136.96

4.6

4.0

13.26

9.57

mg/mmol

2.84

2461

15958

Polyneuropathies and other disorders of the peripheral nervous system

3905

27338

1.72

136.01

5.2

3.8

20.05

9.86

mg/mmol

10.41

2736

17565

Malignant neoplasm of respiratory system and intrathoracic organs

1755

24359

0.51

133.84

3.6

3.9

12.82

9.24

mg/mmol

1.89

1103

15571

Follow-up examination after treatment for conditions other than malignant neoplasms

6964

34487

1.45

133.35

3.9

3.5

10.20

8.65

mg/mmol

1.39

4439

21205

Other joint disorders

14036

60179

1.30

133.27

3.9

3.8

9.60

9.33

mg/mmol

0.18

8931

38862

Dermatitis

10280

81961

1.36

132.30

4.4

3.8

14.75

8.62

mg/mmol

3.24

6782

51352

Abnormalities of heart beat

5797

41998

1.50

132.28

3.9

3.8

9.41

8.57

mg/mmol

0.62

3596

26298

Diabetic retinopathy, excluding more controls

8951

42720

1.80

132.11

6.4

4.2

20.17

3.78

mg/mmol

86.27

6551

28340

Meniscus derangement

9784

52158

1.38

131.58

3.8

3.7

7.03

8.13

mg/mmol

1.68

6086

33080

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3749

25468

1.62

128.47

3.8

3.9

11.85

9.34

mg/mmol

1.51

2320

16591

Adhesive capsulitis of shoulder

2964

19749

1.81

128.33

4.8

3.7

12.39

8.50

mg/mmol

2.70

2059

12194

Any mental disorder

19198

81052

1.25

128.19

3.9

11.22

8.92

mg/mmol

4.81

12239

51630

Acute pancreatitis (for exclusion)

3500

24225

1.72

126.34

4.4

3.8

15.89

9.12

mg/mmol

6.82

2323

15665

Mycoses

13978

100590

1.29

125.77

4.1

3.9

9.18

9.62

mg/mmol

0.43

8843

64171

Degeneration of macula and posterior pole

8545

53860

1.41

124.51

4.1

3.7

12.05

8.50

mg/mmol

6.16

5289

33110

Other neurological diseases

12601

81453

1.31

124.03

3.9

3.8

11.20

9.01

mg/mmol

4.10

8182

51043

Cough

6655

48029

1.44

122.39

4.0

3.8

10.01

8.49

mg/mmol

0.92

4111

30026

Necrosis of pulp, including avohilmo

8935

70648

1.36

121.68

4.1

3.9

8.98

9.10

mg/mmol

0.07

5658

45396

Malignant neoplasm of bronchus and lung

1495

21038

0.51

120.83

3.5

3.9

13.33

9.20

mg/mmol

1.95

949

13397

Mouth breathing

6636

51059

1.45

120.03

4.0

3.9

8.70

9.36

mg/mmol

0.39

4329

33190

Calcific aortic valvular stenosis, operated

5286

38483

1.53

119.30

4.3

3.8

16.04

9.65

mg/mmol

11.56

3667

24398

Calcific aortic valvular stenosis

5286

38483

1.53

119.30

4.3

3.8

16.04

9.65

mg/mmol

11.56

3667

24398

Operations 2 for CAVS

5282

38450

1.53

119.28

4.3

3.8

16.04

9.66

mg/mmol

11.54

3666

24373

Calcific aortic valvular stenosis, diagnosis (helper)

5282

38450

1.53

119.28

4.3

3.8

16.04

9.66

mg/mmol

11.54

3666

24373

6613

50096

1.42

118.62

4.0

3.8

11.30

9.89

mg/mmol

0.93

4266

31739

Amputation of toe

1395

8002

2.46

118.07

6.5

3.8

41.63

8.99

mg/mmol

25.29

1085

5224

Viral and other specified intestinal infections

3517

23141

1.60

117.85

5.1

3.8

14.10

9.96

mg/mmol

3.40

2511

15217

Amputation

1862

11443

2.10

117.69

6.1

3.8

42.30

8.71

mg/mmol

34.29

1434

7355

Calcific aortic valvular stenosis, including rheumatic fever

5294

38595

1.53

117.52

4.3

3.8

16.05

9.65

mg/mmol

11.63

3675

24464

Substance abuse, excluding more controls

9212

62655

1.35

116.85

3.9

14.31

8.90

mg/mmol

12.25

6009

41271

Cerebrovascular diseases

13244

77459

1.30

116.22

4.1

3.8

14.63

8.14

mg/mmol

23.97

8653

48429

Viral and other specified intestinal infections

2624

16490

1.71

115.26

5.5

3.9

15.25

10.02

mg/mmol

3.61

1899

10996

Hernia

15806

89140

1.26

114.96

3.9

9.37

9.25

mg/mmol

0.09

10026

56362

Other headache syndromes

6199

47076

1.43

114.65

3.6

3.8

8.41

8.69

mg/mmol

0.14

3683

28889

COPD/asthma related infections

17666

74776

1.25

114.25

4.1

3.7

12.68

7.39

mg/mmol

23.36

11508

46607

COPD/asthma/ILD related infections

17666

74776

1.25

114.25

4.1

3.7

12.68

7.39

mg/mmol

23.36

11508

46607

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9599

77576

1.34

113.59

4.1

3.8

14.87

8.70

mg/mmol

15.97

6284

48535

Intestinal infectious diseases

19411

94722

1.23

113.40

4.4

3.7

14.34

8.47

mg/mmol

8.51

12833

59734

Recurrent or chronic depression

6254

33258

1.43

113.05

3.9

8.52

8.57

mg/mmol

0.03

3936

21057

Cellulitis

3555

25017

1.63

112.98

4.9

3.8

20.67

8.58

mg/mmol

15.35

2487

16167

Other pulmonary diagnosis

13833

57394

1.28

111.14

4.0

3.7

12.27

6.96

mg/mmol

20.73

8961

36154

Malignant neoplasm of bronchus and lung, including Hilmo

1930

25202

0.56

111.08

3.7

3.9

13.03

9.26

mg/mmol

2.20

1251

16064

Peripheral artery operations in Hilmo

2294

14956

1.88

110.62

5.9

3.7

37.12

8.28

mg/mmol

35.77

1730

9539

Syncope and collapse

7838

53014

1.38

110.54

4.0

3.8

12.37

7.60

mg/mmol

11.72

5004

33167

Injuries to the knee and lower leg

19871

94717

1.22

108.06

3.9

10.75

9.19

mg/mmol

3.00

12700

60315

Poisoning by drugs, medicaments and biological substances

3276

22656

1.61

107.42

3.9

10.42

9.96

mg/mmol

0.19

2048

14795

Excluding asthma or asthma-COPD overlap

13783

57394

1.27

106.61

4.0

3.7

12.22

6.96

mg/mmol

19.97

8926

36154

Oter anti-inflammatory and antirheumatic agents, non-steroids

4024

15815

1.58

106.45

3.8

4.2

10.20

12.00

mg/mmol

1.16

2559

10599

Other and unspecified dermatitis

8340

66810

1.35

106.29

4.4

3.8

14.77

8.71

mg/mmol

2.33

5496

41685

Headache

10430

67862

1.30

105.83

3.9

3.8

10.29

7.51

mg/mmol

4.23

6598

42300

Fitting and adjustment of other devices

6400

45085

1.43

104.96

3.9

3.7

8.77

7.05

mg/mmol

2.47

4460

27456

Asthma, hospital admissions , main diagnosis only

13066

96353

1.27

104.45

3.8

3.9

9.06

9.68

mg/mmol

0.64

8274

61079

Thyroiditis, ILD-related definition

1760

10800

1.95

103.70

5.1

3.7

9.20

9.14

mg/mmol

0.02

1198

6612

COPD differential diagnosis

13719

57282

1.27

103.12

4.0

3.7

12.08

7.03

mg/mmol

18.84

8873

36117

19423

86260

1.22

103.07

4.1

3.8

12.10

8.52

mg/mmol

12.46

12412

54367

ILD differential diagnosis

13714

57269

1.27

102.91

4.0

3.7

12.07

7.03

mg/mmol

18.82

8871

36108

Injuries to the head

18361

96843

1.22

102.45

4.0

3.9

11.03

9.36

mg/mmol

3.31

11678

61812

Anaemia in chronic diseases classified elsewhere

540

2326

4.37

102.35

10.9

3.7

71.31

8.30

mg/mmol

20.96

487

1472

Disorders of skin appendages

7002

54926

1.37

102.01

4.4

3.9

12.75

9.36

mg/mmol

3.78

4632

34997

Other reaction to severe stress, and adjustment disorders

4940

36857

1.45

101.88

4.3

3.9

10.75

9.52

mg/mmol

0.90

3273

23468

Candidiasis

4261

31378

1.51

101.12

4.3

3.8

10.64

10.29

mg/mmol

0.13

2672

19355

Schizophrenia

2440

16259

1.74

100.46

3.8

3.9

8.20

9.46

mg/mmol

0.50

1516

10721

Excessive, frequent and irregular menstruation

5220

21231

1.45

100.44

3.9

3.7

9.45

10.25

mg/mmol

0.47

3123

12715

Falls/tendency to fall

18122

77623

1.22

100.40

4.0

3.8

11.32

8.94

mg/mmol

5.19

11661

49834

Other diseases of pancreas

1499

9139

2.17

99.98

4.8

3.8

16.87

9.28

mg/mmol

3.63

1013

5732

All influenza

4088

30039

1.53

99.60

4.4

3.8

18.50

7.85

mg/mmol

13.36

2758

19218

Other functional intestinal disorders

7379

54364

1.36

99.45

4.1

3.8

11.81

8.92

mg/mmol

3.63

4641

33944

Hypokalaemia

1967

12637

1.88

98.86

4.1

3.5

24.65

6.84

mg/mmol

1.42

1320

7526

Familial hypercholesterolemia, with ischemic heart disease

1707

10822

2.04

97.49

4.7

3.7

12.33

8.46

mg/mmol

2.41

1176

6809

Menorrhagia

4891

20125

1.47

97.44

3.8

3.7

7.31

9.63

mg/mmol

2.62

2849

11854

9915

71749

1.30

97.41

4.0

3.9

14.14

9.20

mg/mmol

11.75

6545

47470

Volume depletion

1557

9453

2.01

97.23

5.1

3.5

20.68

7.68

mg/mmol

10.42

1123

5887

Diseases of the digestive system

7562

60336

1.36

97.04

4.4

3.8

16.79

9.32

mg/mmol

15.37

5100

38293

Umbilical hernia

4610

34869

1.50

96.69

4.3

4.0

10.12

9.38

mg/mmol

0.33

3125

23068

Poisoning by medicine

2924

20197

1.61

96.49

3.8

3.9

10.60

9.85

mg/mmol

0.32

1841

13205

Other and unspecified nonorganic psychotic disorders

2582

17402

1.66

96.04

3.7

4.0

9.48

9.98

mg/mmol

0.14

1559

11467

Chronic gastritis

4706

35770

1.49

95.66

4.3

3.7

11.62

8.69

mg/mmol

3.00

2959

22014

Oxicams

4041

16656

1.52

94.39

3.6

4.3

8.94

12.43

mg/mmol

2.35

2654

11236

Status post-ami

4619

26664

1.50

94.00

4.3

3.8

13.94

8.43

mg/mmol

8.96

3205

16913

Psychiatric diseases

17139

73585

1.22

93.62

3.9

11.05

9.04

mg/mmol

3.40

10941

46928

Diabetic retinopathy, strict definition

5317

39556

1.87

92.90

7.7

4.4

27.89

6.88

mg/mmol

63.01

4076

27522

Alcohol use disorder, Swedish definition

9019

67801

1.31

91.85

4.0

3.9

14.41

9.21

mg/mmol

11.68

5956

44979

Alcohol-induced chronic pancreatitis

1189

6984

2.32

91.64

4.9

3.9

16.07

9.08

mg/mmol

3.78

834

4670

Exclusions for E4_PCOS_CONSORTIUM

10185

52434

1.28

90.51

3.8

9.53

9.34

mg/mmol

0.09

6016

31999

Other gastritis (incl. Duodenitis)

3804

28234

1.53

90.32

4.3

3.7

14.73

8.76

mg/mmol

7.06

2535

17676

5066

34120

1.46

90.18

3.9

3.6

12.01

9.12

mg/mmol

2.57

3095

21010

Other/unspecified dorsalgia

5848

45342

1.39

89.29

3.9

3.8

9.61

9.46

mg/mmol

0.08

3656

28443

Any operation in hilmo

566

1104

2.90

88.93

3.9

2.9

12.83

1.49

mg/mmol

5.06

390

771

Hypo-osmolality and hyponatraemia

2830

19905

1.63

88.79

4.4

3.5

21.03

6.89

mg/mmol

18.11

1827

11910

Coxibs

4522

17672

1.46

87.75

3.7

4.4

8.38

12.65

mg/mmol

7.36

2878

12049

Presence of other devices

3969

29671

1.50

86.29

4.0

3.6

8.16

8.95

mg/mmol

0.58

2651

18472

Papulosquamous disorders

6291

50146

1.37

86.11

4.0

3.8

10.17

8.74

mg/mmol

1.34

4046

31409

9400

70341

1.29

85.89

4.1

3.9

14.41

9.22

mg/mmol

12.06

6210

46625

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3749

27548

1.48

85.44

3.8

3.9

11.85

10.06

mg/mmol

0.91

2320

18022

Glaucoma

9680

69492

1.30

85.44

4.2

3.8

10.76

9.03

mg/mmol

2.09

5995

43134

Mental and behavioural disorders due to psychoactive substance use

9539

73315

1.28

85.20

4.0

3.9

14.14

9.27

mg/mmol

10.56

6213

48432

Osteomyelitis

1150

6785

2.24

85.17

6.5

3.9

38.44

9.04

mg/mmol

18.52

892

4449

Fibromyalgia

1291

7644

2.00

84.95

3.2

3.6

6.31

8.29

mg/mmol

0.75

763

4565

Pure hyperglyceridaemia

472

2041

3.84

84.88

5.3

3.6

13.16

6.83

mg/mmol

1.81

364

1282

Diabetic retinopathy

10862

60338

1.49

84.61

6.2

4.5

19.39

6.90

mg/mmol

65.15

7925

41552

Adjustment and management of implanted device

3185

23317

1.58

84.39

4.2

3.7

13.64

7.60

mg/mmol

7.67

2071

14508

Exposure to unspecified factor

16102

100128

1.21

84.23

4.1

3.8

11.47

9.33

mg/mmol

4.39

10136

64009

Diseases of male genital organs

8742

36036

1.31

83.47

4.3

3.9

10.67

10.10

mg/mmol

0.32

6073

25072

Acidosis

454

1973

4.10

83.17

5.9

3.6

20.60

6.30

mg/mmol

4.22

338

1246

Pain, not elsewhere classified

4282

32446

1.45

83.04

3.8

10.71

7.55

mg/mmol

3.73

2846

20153

Periapical abscess

7059

57150

1.34

82.54

4.0

3.9

10.49

8.73

mg/mmol

1.71

4566

36508

Cirrhosis of liver, NAS

1008

5874

2.43

81.96

4.6

3.8

15.82

8.11

mg/mmol

3.89

742

3780

Acute sinusitis

7563

56811

1.31

81.26

4.3

3.8

11.03

8.81

mg/mmol

2.78

4872

36208

Cystitis

13646

69240

1.23

81.17

4.1

3.7

11.52

8.51

mg/mmol

8.31

8921

43126

Disorders of vitreous body and globe

8651

69180

1.31

80.56

4.5

3.8

14.28

8.57

mg/mmol

12.24

5506

42400

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

11087

84134

1.26

80.23

4.1

3.8

12.83

8.96

mg/mmol

6.91

7210

52636

Mixed and other personality disorders

1135

6610

2.06

79.91

3.9

10.32

9.16

mg/mmol

0.24

691

4324

Emotionally unstable personality disorder

1440

8805

1.84

79.89

3.8

3.9

9.25

10.91

mg/mmol

0.57

903

5844

Disorders of vitreous body

8422

67690

1.31

79.18

4.5

3.8

14.14

8.50

mg/mmol

11.86

5348

41415

Schizoaffective disorder

1122

6564

2.07

78.88

3.8

3.9

8.11

9.42

mg/mmol

0.20

701

4214

Disorders of mineral metabolism

1346

8362

1.98

78.35

5.2

3.5

33.62

6.86

mg/mmol

1.61

950

5109

Asthma-related pneumonia or sepsis

5682

45055

1.37

78.08

4.0

3.8

14.04

10.15

mg/mmol

3.94

3853

28240

Asthma, hospital admissions 3, pneumonia

5682

45055

1.37

78.08

4.0

3.8

14.04

10.15

mg/mmol

3.94

3853

28240

Substance abuse

9212

72179

1.28

78.07

3.9

4.0

14.31

9.24

mg/mmol

10.87

6009

47740

Other specified/unspecified arthritis

4136

31537

1.44

77.72

4.3

3.7

14.11

8.21

mg/mmol

7.46

2731

19696

Asthma-related pneumonia

5670

44976

1.37

77.72

4.0

3.8

14.05

10.15

mg/mmol

3.95

3846

28195

Diarrhoea and gastroenteritis of presumed infectious origin

16455

94358

1.20

77.24

4.5

3.7

14.48

8.42

mg/mmol

7.07

11094

59408

Alzheimer’s disease, strict definition

2313

26937

0.64

77.12

3.2

3.7

10.07

10.22

mg/mmol

0.04

1412

16841

Gout due to impairment of renal function

283

1048

7.71

77.01

9.9

3.7

40.72

9.26

mg/mmol

8.02

258

680

Diabetic maculopathy

3798

29748

1.97

76.75

7.6

4.5

29.02

6.73

mg/mmol

50.25

2978

20795

Ventral hernia

3959

30303

1.47

76.38

4.3

3.8

10.61

9.18

mg/mmol

0.94

2597

19030

Injuries to the shoulder and upper arm

13830

96216

1.22

75.77

3.9

8.86

9.52

mg/mmol

0.75

8870

61185

Other and unspecified nerve root and plexus disorders, also in other diseases

3008

22012

1.54

75.76

3.8

6.94

8.85

mg/mmol

1.77

1881

13951

Transient ischemic attack

9067

61566

1.29

75.52

3.8

10.76

8.59

mg/mmol

3.10

5823

38310

Other arthritis (FG)

4721

36797

1.40

75.23

4.3

3.7

14.42

8.22

mg/mmol

9.02

3107

22917

ILD medications: azathioprine

2143

14714

1.65

75.10

6.8

3.6

24.92

8.62

mg/mmol

1.70

1631

9375

Fibrosis and cirrhosis of liver

1340

8531

2.02

75.05

4.6

3.8

17.19

8.70

mg/mmol

4.56

959

5388

Cervical disc disorders

5996

48288

1.35

74.98

3.7

3.8

7.19

8.91

mg/mmol

2.23

3767

30300

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2114

14397

1.64

74.91

3.8

3.9

10.70

10.09

mg/mmol

0.19

1297

9490

Dermatitis and eczema

18016

97964

1.19

74.43

4.2

3.8

12.12

8.99

mg/mmol

9.03

11589

62370

Psoriasis

4417

34312

1.42

74.43

4.1

3.9

10.65

9.04

mg/mmol

1.17

2900

21846

Urolithiasis

5317

42394

1.38

74.31

4.2

3.9

9.20

9.84

mg/mmol

0.40

3829

27686

Polyuria

3710

28319

1.48

73.94

4.0

3.8

9.95

9.05

mg/mmol

0.58

2343

18100

Covid-19 suspected case

2880

20832

1.52

73.50

4.4

3.9

7.63

9.88

mg/mmol

2.21

2265

13370

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1239

7604

1.95

73.37

5.0

3.6

21.98

6.95

mg/mmol

9.90

862

4328

Degenerative diseases of the nervous system

3827

36481

0.71

72.61

3.2

3.8

10.67

9.90

mg/mmol

0.41

2359

22898

Calculus of kidney and ureter

4897

38783

1.40

72.50

4.2

3.9

8.53

9.68

mg/mmol

1.21

3522

25298

Anosmia

273

854

3.85

72.31

4.0

1.7

9.60

5.30

mg/mmol

0.67

161

414

Retention of urine

5848

38677

1.36

72.27

4.2

3.9

14.85

9.07

mg/mmol

11.22

4059

25139

Suicide or other Intentional self-harm

3292

24440

1.47

72.04

3.8

3.9

11.30

9.63

mg/mmol

0.74

2006

15900

Disorders of parathyroid gland

3277

24298

1.51

71.95

5.5

3.6

22.20

8.65

mg/mmol

17.51

2212

14462

Symptoms and signs involving the skin and subcutaneous tissue

11100

92799

1.24

71.54

4.1

3.8

11.14

9.21

mg/mmol

2.81

7075

58341

Acetic acid derivatives and related substances

4440

17583

1.41

71.34

3.9

4.3

10.25

12.68

mg/mmol

2.14

2837

11972

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2283

16199

1.63

71.17

5.1

3.7

18.79

8.80

mg/mmol

9.00

1576

10134

Fracture of lower leg, including ankle

8753

72641

1.27

70.96

4.1

3.8

10.99

8.67

mg/mmol

3.36

5670

45406

Disorders of calcium metabolism

1038

6224

2.10

70.15

5.4

3.6

39.28

6.78

mg/mmol

1.52

754

3761

Lung transplantation

207

667

10.01

70.11

5.1

3.9

12.01

9.81

mg/mmol

0.23

164

427

Isolated proteinuria with specified morphological lesion

273

1017

5.92

69.76

12.2

3.5

75.19

6.34

mg/mmol

22.30

254

637

Lung transplant status

206

666

10.05

69.52

5.1

3.9

12.06

9.81

mg/mmol

0.23

163

427

Other abnormal uterine and vaginal bleeding

3288

17505

1.48

69.27

3.9

3.6

7.66

9.36

mg/mmol

1.06

1827

10191

Hyperparathyroidism

2904

21311

1.53

68.80

5.7

3.6

23.56

8.48

mg/mmol

18.24

1989

12722

Azathioprine

2143

14977

1.61

68.65

6.8

3.8

24.92

9.19

mg/mmol

1.60

1631

9614

Soft tissue disorders related to use, overuse and pressure

4305

33684

1.41

68.39

3.8

3.7

10.03

8.03

mg/mmol

1.95

2759

20870

Lupus nephritis

114

225

19.12

68.39

19.1

3.1

48.69

15.77

mg/mmol

2.22

106

130

Benign neoplasm: Colon, unspecified

4231

33318

1.43

68.34

4.4

3.8

13.34

9.19

mg/mmol

4.84

2784

20907

Viral infections characterized by skin and mucous membrane lesions

6243

50796

1.32

68.07

4.7

3.8

13.05

9.44

mg/mmol

4.06

4233

32315

Psoriasis vulgaris

2865

21246

1.52

67.61

4.2

3.9

12.10

9.49

mg/mmol

1.51

1910

13722

Rheumatism, unspecified

2100

14765

1.64

67.57

3.8

3.6

6.47

7.55

mg/mmol

0.49

1218

8495

Glaucoma suspect

5901

48170

1.34

67.45

4.2

3.8

9.11

8.90

mg/mmol

0.12

3615

29516

Alzheimer disease

3313

31782

0.70

67.43

3.2

3.8

10.88

10.06

mg/mmol

0.39

2033

19862

Problems related to lifestyle

1476

9575

1.77

67.37

4.3

3.8

17.06

9.09

mg/mmol

3.19

999

6193

Lung cancer and mesothelioma

1970

23796

0.63

67.31

3.7

3.8

12.62

6.96

mg/mmol

4.74

1269

14908

Hyperplasia of prostate

6489

30108

1.34

67.31

4.2

3.9

9.24

9.72

mg/mmol

0.30

4482

20772

Alzheimer’s disease (Late onset)

2115

24948

0.65

67.28

3.1

3.7

10.46

10.41

mg/mmol

0.01

1285

15604

Myalgia

3321

24971

1.45

67.25

3.9

3.7

9.84

8.84

mg/mmol

0.47

1965

15479

Maternal care for other known or suspected fetal problems

2151

9239

1.57

67.04

4.6

3.8

13.55

10.24

mg/mmol

1.76

1549

5947

6922

52720

1.32

66.73

4.2

3.8

9.06

9.50

mg/mmol

0.34

4309

32692

Coxarthrosis, primary

10293

74785

1.25

66.27

3.7

3.8

8.66

9.03

mg/mmol

0.33

6470

46422

Viral pneumonia

2013

14096

1.64

66.17

4.8

3.8

20.26

7.72

mg/mmol

8.00

1362

8982

Polyarthrosis

3283

23138

1.48

66.03

3.7

3.6

8.77

7.86

mg/mmol

0.42

1926

13670

Viral infections characterized by skin and mucous membrane lesions

13451

100065

1.20

65.64

4.3

3.8

10.91

9.35

mg/mmol

2.39

8706

63545

Other disorders of eyelid

7436

59181

1.29

65.41

3.8

9.30

9.22

mg/mmol

0.04

4620

36399

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2185

14959

1.58

65.18

6.0

3.9

21.43

9.86

mg/mmol

1.03

1636

9800

Other specified and unspecified personality disorders

1234

7750

1.85

65.03

4.0

3.9

9.66

9.52

mg/mmol

0.03

760

5045

Persistent mood disorders

2777

20490

1.50

64.76

4.0

3.8

11.21

9.34

mg/mmol

0.77

1709

12842

Mycoses

4010

31349

1.41

64.18

4.4

3.9

12.43

9.45

mg/mmol

2.52

2694

19881

Substance use, excluding alcohol

2703

19869

1.50

63.63

4.0

15.52

9.23

mg/mmol

4.21

1700

13087

Dental pulpitis, including avohilmo

13833

78188

1.20

63.57

3.9

8.83

9.26

mg/mmol

0.47

8915

50191

Stroke, including SAH

10884

68113

1.23

63.28

4.0

3.8

15.13

8.38

mg/mmol

20.65

7159

42629

Systemic connective tissue disorders

5337

43214

1.34

63.07

4.8

3.7

12.94

8.97

mg/mmol

4.93

3497

26243

Other necrotizing vasculopathies (FG)

1015

6270

2.06

62.66

7.8

3.7

20.75

8.56

mg/mmol

7.17

756

3847

Skin changes due to chronic exposure to nonionizing radiation

6543

50203

1.32

62.61

4.2

3.8

8.97

9.49

mg/mmol

0.41

4061

31111

Diseases of the respiratory system

10975

46960

1.23

62.57

3.9

3.7

11.64

7.22

mg/mmol

10.57

7019

29432

Late syphilis

301

1249

4.68

62.02

7.8

3.8

43.23

9.16

mg/mmol

5.63

250

812

Acute bronchitis

6054

48575

1.30

61.97

4.3

3.8

14.71

9.93

mg/mmol

5.57

3888

30861

Late syphilis

347

1529

4.02

61.94

7.5

3.8

41.18

9.05

mg/mmol

5.95

280

981

Actinic keratosis

6370

49015

1.32

61.79

4.2

3.8

8.85

9.47

mg/mmol

0.53

3964

30382

Paracetamol or NSAID medication

2498

8879

1.51

61.55

4.0

11.02

10.16

mg/mmol

0.32

1645

6004

Other acute lower respiratory infections

7904

63220

1.26

61.35

4.3

3.8

14.57

9.81

mg/mmol

7.61

5228

40549

Otitis externa

3179

24186

1.45

61.22

4.5

3.8

10.19

9.56

mg/mmol

0.30

2028

15516

Visual disturbances and blindness

7966

67133

1.26

61.21

4.0

3.8

10.09

9.25

mg/mmol

0.68

4875

42248

Unspecified nephritic syndrome

432

2081

3.21

60.45

9.9

3.6

40.53

6.64

mg/mmol

12.40

366

1339

Symptoms and signs involving the nervous and musculoskeletal systems

9011

76835

1.24

60.17

3.9

3.8

9.78

9.56

mg/mmol

0.13

5897

48371

Other metabolic disorders

1760

12130

1.63

59.95

4.0

3.5

12.02

6.64

mg/mmol

2.86

1108

7119

Any dementia

4542

39173

0.74

59.91

3.4

3.8

12.55

9.65

mg/mmol

2.09

2881

24458

Other external causes of accidental injury

13604

59321

1.19

59.73

3.9

3.8

10.98

8.82

mg/mmol

3.56

8635

38099

Acute and transient psychotic disorders

1630

11130

1.67

59.40

3.9

3.8

8.74

9.32

mg/mmol

0.14

983

7120

Impingement syndrome of shoulder

3906

30831

1.40

59.31

4.0

3.8

7.59

8.02

mg/mmol

0.23

2445

19286

Necrobiosis lipoidica, not elsewhere classified

147

403

9.21

59.12

7.6

3.8

24.54

8.47

mg/mmol

1.69

117

248

Other follicular disorders

1016

6257

1.92

58.81

5.0

3.9

16.98

9.33

mg/mmol

2.32

685

4085

Anxiety (asthma-related co-morbidities)

8176

53146

1.24

58.74

3.8

9.99

8.62

mg/mmol

1.35

5212

33861

3440

25176

1.44

58.70

3.9

3.6

11.86

8.93

mg/mmol

1.71

2027

15385

Disorders of sclera, cornea, iris and ciliary body

8301

70443

1.25

58.49

4.3

3.8

11.79

8.89

mg/mmol

5.06

5448

44579

Phobic anxiety disorders

1458

9588

1.66

58.23

4.0

16.47

10.37

mg/mmol

1.64

944

6457

Hyperaldosteronism

525

2777

2.80

57.57

4.6

3.7

14.25

8.30

mg/mmol

1.75

346

1775

Non-small cell lung cancer, including Hilmo

1385

19054

0.61

57.46

3.7

3.9

10.89

9.03

mg/mmol

0.75

889

12133

Diseases of external ear

5082

41341

1.33

57.30

4.3

3.8

10.23

9.40

mg/mmol

0.53

3165

26396

Background retinopathy and retinal vascular changes

396

1875

3.22

57.18

6.6

3.7

32.46

7.49

mg/mmol

7.32

291

1224

549

9945

0.47

57.09

3.1

3.9

17.16

9.91

mg/mmol

2.24

361

6683

Lesion of ulnar nerve

2096

15183

1.57

57.02

3.9

3.7

9.31

9.13

mg/mmol

0.06

1386

9785

External causes of morbidity and mortality

10877

46801

1.21

56.96

3.9

3.8

10.81

8.34

mg/mmol

3.43

7007

29841

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2393

17879

1.55

56.84

4.4

3.9

16.24

9.18

mg/mmol

6.59

1641

11711

Stroke, excluding SAH

10282

65029

1.23

56.77

4.0

3.8

15.26

8.57

mg/mmol

19.07

6762

40764

Other sleep disorders

1620

11182

1.65

56.34

4.2

3.8

9.98

9.76

mg/mmol

0.06

1112

7203

Anxiety disorders, excluding more controls

12778

72622

1.19

56.32

3.9

3.8

9.56

8.47

mg/mmol

1.41

8039

45848

Chronic ulcer of skin, not elsewhere classified

1142

7450

1.90

56.21

5.2

3.7

25.71

8.80

mg/mmol

8.97

851

4699

GI-bleeding

5124

41910

1.32

55.66

4.2

3.8

17.70

9.38

mg/mmol

15.82

3534

26845

Other diseases of lip and oral mucosa

5995

49750

1.29

55.46

3.9

3.8

7.20

9.14

mg/mmol

2.19

3676

30886

Renal tubulo-interstitial disorders in diseases classified elsewhere

226

860

5.57

55.40

9.8

3.5

35.73

6.32

mg/mmol

3.65

205

512

Other enthesopathies

4430

35554

1.34

55.38

3.8

3.7

7.30

7.93

mg/mmol

0.41

2743

21987

Other diseases of the digestive system

5113

41869

1.32

55.09

4.2

3.8

17.61

9.38

mg/mmol

15.35

3488

26774

Retinal vascular occlusion

1927

13962

1.61

55.00

4.3

3.7

13.45

8.59

mg/mmol

4.07

1292

8760

Functional dyspepsia

3943

31337

1.37

54.17

3.9

3.7

9.64

8.54

mg/mmol

0.60

2367

19289

Other noninflammatory disorders of uterus, except cervix

3225

16766

1.43

53.75

3.7

3.6

6.73

8.59

mg/mmol

1.36

1845

9595

Wet age-related macular degeneration

2781

20692

1.47

53.65

3.8

3.6

11.56

9.31

mg/mmol

1.42

1732

12704

Postmenopausal bleeding

4065

17159

1.38

53.64

3.7

3.5

6.96

8.21

mg/mmol

0.74

2235

9762

Early onset COPD, excluding more controls

3420

26888

1.41

53.58

4.0

3.8

16.46

6.70

mg/mmol

10.49

2223

17105

Benign neoplasm: Sigmoid colon

3092

24156

1.45

53.53

4.2

3.8

10.45

9.31

mg/mmol

0.62

2081

15181

Other anxiety disorders

5829

41508

1.28

53.48

3.8

3.9

9.63

9.65

mg/mmol

0.01

3724

26774

SLE (Finngen)

523

2741

2.45

53.44

7.4

3.3

21.73

7.59

mg/mmol

3.38

382

1637

Chronic tubulo-interstitial nephritis

629

3532

2.31

53.41

7.0

3.3

20.85

5.13

mg/mmol

7.45

483

2045

Retinal vascular disorders

1947

14191

1.59

53.33

4.3

3.7

13.41

8.61

mg/mmol

4.05

1305

8898

Gingival hyperplasia

575

3167

2.42

52.80

6.8

3.9

54.14

7.99

mg/mmol

1.11

431

2042

Any prescribed medicine buy

17.14

52.54

3.9

2.1

8.49

24.85

mg/mmol

0.30

Accidents

13491

59321

1.18

52.49

3.9

3.8

11.09

8.82

mg/mmol

3.80

8591

38099

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4809

39202

1.32

52.49

4.0

3.8

9.09

mg/mmol

0.00

2990

24073

Other necrotizing vasculopathies

1171

7837

1.84

51.89

7.7

3.8

22.79

8.84

mg/mmol

7.41

868

4874

Cervicobrachial syndrome

3225

25129

1.40

51.70

3.5

3.8

7.90

8.72

mg/mmol

0.42

2052

15604

Other disorders of lacrimal gland

5169

42581

1.31

51.67

4.0

3.7

11.12

8.79

mg/mmol

1.47

3136

25933

Ovarian cyst

4525

20837

1.32

51.55

3.7

8.88

10.27

mg/mmol

1.00

2675

12402

Cholecystitis

2163

16017

1.52

51.52

4.1

3.8

13.72

9.51

mg/mmol

2.37

1435

10090

Irregular menses

5566

36053

1.28

51.30

4.0

3.7

9.18

8.99

mg/mmol

0.10

3420

21271

Myocarditis

587

3170

2.16

50.93

3.9

3.2

11.21

3.31

mg/mmol

3.42

401

1878

Visual disturbances

7264

61742

1.25

50.89

3.9

3.8

9.28

9.27

mg/mmol

0.01

4436

38789

Ovarian dysfunction

735

4213

1.95

50.76

3.9

9.04

12.36

mg/mmol

0.95

471

2761

Superficial injury of lower leg

3410

26774

1.37

50.46

4.0

3.8

10.84

9.41

mg/mmol

0.84

2142

16867

Ischaemic Stroke, excluding all haemorrhages

9580

62014

1.22

50.37

4.0

3.8

14.53

8.72

mg/mmol

14.93

6295

38889

Neoplasms

11246

51752

1.19

50.36

4.1

3.8

12.83

8.87

mg/mmol

1.87

7493

33885

Viral warts

1338

9089

1.68

50.20

6.0

3.9

14.96

9.45

mg/mmol

2.60

965

5817

Other diseases of upper respiratory tract

18306

85684

1.15

50.11

3.8

3.9

9.15

9.84

mg/mmol

0.75

11445

54967

Amputation of foot

485

2634

2.75

50.10

6.6

3.9

49.81

9.16

mg/mmol

12.50

388

1755

Other and unspecified local infections of skin and subcutaneous tissue

1410

9744

1.68

49.95

4.7

3.8

18.02

8.66

mg/mmol

4.60

956

6225

Hidradenitis suppurativa

502

2632

2.36

49.73

4.6

3.9

14.72

9.14

mg/mmol

0.86

345

1720

Exclusions for E4_PCOS_BROAD

2277

16963

1.48

49.71

4.2

3.9

10.67

10.62

mg/mmol

0.01

1509

10947

Hydronephrosis

1727

12409

1.59

49.66

5.0

3.5

21.88

4.96

mg/mmol

18.92

1292

7569

Bell's palsy

1712

12254

1.59

49.66

4.2

3.7

9.63

9.45

mg/mmol

0.05

1142

7764

Fibroblastic disorders

3704

29638

1.37

49.43

4.1

3.8

10.34

9.23

mg/mmol

0.61

2339

18886

Excessive attrition of teeth

7926

67850

1.23

49.28

4.1

3.9

8.72

9.25

mg/mmol

0.39

4868

43388

Polycystic ovarian syndrome

520

2693

2.17

49.12

3.7

4.1

8.07

15.24

mg/mmol

3.38

352

1816

Other systemic involvement of connective tissue (FG)

3750

29563

1.35

49.07

3.8

3.6

8.87

8.35

mg/mmol

0.26

2351

17749

Mental and behavioural disorders due to alcohol

7916

65251

1.23

48.90

4.0

14.32

9.31

mg/mmol

9.35

5182

43406

Nonorganic sleeping disorders, excluding more controls

2389

17868

1.44

48.89

3.7

3.9

8.37

9.00

mg/mmol

0.31

1510

11577

Other skin changes

2852

22211

1.43

48.83

4.8

3.8

13.87

9.49

mg/mmol

3.26

1914

13979

Gastroduodenal ulcer

4182

33874

1.34

48.78

4.3

3.8

16.22

9.30

mg/mmol

10.60

2884

21513

Benign neoplasm of other and ill-defined parts of digestive system

2761

21449

1.45

48.73

4.2

3.8

12.62

9.00

mg/mmol

2.44

1788

13247

Other local infections of skin and subcutaneous tissue

1492

10471

1.64

48.66

4.7

3.8

17.39

8.61

mg/mmol

4.48

1006

6719

Disorders of lacrimal system

6375

53694

1.26

48.54

4.0

3.7

10.30

8.66

mg/mmol

1.14

3864

32716

Bronchitis

17105

96700

1.15

48.44

4.2

3.8

12.76

8.76

mg/mmol

13.75

11124

61246

Other CVD

3086

24303

1.41

48.19

4.2

3.8

15.89

9.79

mg/mmol

4.75

1993

15338

Any dementia, excluding more controls

4303

36113

0.76

48.02

3.4

3.8

12.79

9.10

mg/mmol

2.90

2731

22486

Benign neoplasm: Adrenal gland

1255

8687

1.76

47.77

4.1

3.8

12.68

8.48

mg/mmol

1.44

877

5417

Polyp of the female genital tract

4192

19305

1.33

47.74

3.6

7.01

9.14

mg/mmol

1.81

2337

11239

Panic disorder

1655

11653

1.54

47.74

3.8

4.0

11.06

10.47

mg/mmol

0.16

1054

7628

Hypotension

2672

20711

1.45

47.53

4.3

3.8

16.05

9.88

mg/mmol

4.19

1730

13142

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

15770

90491

1.16

47.42

4.0

3.8

10.87

8.87

mg/mmol

4.78

9874

57625

Dermatophytosis

9359

81411

1.20

47.33

4.0

3.9

8.91

9.57

mg/mmol

0.58

5960

52246

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1579

11149

1.58

47.28

4.0

3.5

12.11

6.80

mg/mmol

2.48

985

6521

Injury, poisoning and certain other consequences of external causes

8778

37711

1.21

47.01

3.9

3.8

12.15

8.05

mg/mmol

1.32

5640

23819

Primary hyperparathyroidism

1690

12320

1.60

46.85

4.3

3.7

13.53

8.28

mg/mmol

3.44

1089

7296

Irritable bowel syndrome

3796

30461

1.33

46.67

3.9

3.7

9.76

8.73

mg/mmol

0.50

2235

18778

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2640

33253

0.71

46.65

3.5

3.9

11.68

8.84

mg/mmol

2.14

1682

21094

Iron deficiency anaemia secondary to blood loss (chronic)

2424

18558

1.45

46.15

4.5

3.7

20.48

8.82

mg/mmol

11.93

1654

11529

KRA_PSY_EATING, excluding more controls

699

4004

1.88

46.08

4.5

4.1

10.53

13.43

mg/mmol

0.72

450

2772

Explicit bacterial Sepsis

1598

11486

1.59

45.68

4.9

3.7

25.89

7.33

mg/mmol

12.17

1162

7284

Cardiac arrest

872

4639

1.83

45.68

4.2

3.2

22.66

3.01

mg/mmol

8.83

592

2682

Intestinal malabsorption

718

4378

2.04

45.65

5.4

3.9

20.24

7.95

mg/mmol

4.57

496

2763

Benign neoplasm: Transverse colon

1743

12906

1.60

45.38

4.5

3.8

13.79

9.66

mg/mmol

2.38

1240

8164

Flat foot [pes planus] (acquired)

1402

9850

1.63

45.29

3.5

3.6

4.71

7.88

mg/mmol

3.11

781

5904

Diaphragmatic hernia

5761

48715

1.27

45.10

3.8

10.52

9.15

mg/mmol

0.90

3540

30033

Other disorders of penis

1453

10321

1.63

45.09

4.5

4.0

14.00

11.19

mg/mmol

0.57

979

7149

Impotence

917

6034

1.91

44.81

5.2

3.9

15.30

10.22

mg/mmol

1.50

663

4167

Cardiomyopathy

2710

21158

1.42

44.78

4.0

3.8

15.17

6.26

mg/mmol

12.25

1901

13522

Triptan medication for migraine, single purchase ok

8359

65503

0.83

44.64

3.4

3.9

7.43

9.21

mg/mmol

2.76

5032

40956

Migraine, single triptan purchase ok & required. ICD-code if available is included

8359

65503

0.83

44.64

3.4

3.9

7.43

9.21

mg/mmol

2.76

5032

40956

Wegener granulomatosis

306

1463

3.35

44.53

11.7

3.7

15.32

10.06

mg/mmol

1.49

262

927

Alzheimer disease, including avohilmo

4235

36196

0.77

44.52

3.3

3.8

9.83

9.97

mg/mmol

0.06

2622

22515

Blepharochalasis

4696

39130

1.31

44.36

3.8

3.7

8.19

8.47

mg/mmol

0.10

2809

23590

Trochanteric bursitis

2079

15645

1.48

44.32

3.5

3.6

8.11

8.08

mg/mmol

0.01

1258

9180

Sarcoidosis

1954

14645

1.51

43.70

4.4

3.8

9.60

8.76

mg/mmol

0.37

1291

9285

All anxiety disorders

8250

56220

1.20

43.55

3.8

3.9

10.14

9.29

mg/mmol

0.66

5269

35967

Sequelae of external causes of morbidity and mortality

3836

31284

1.33

43.24

4.1

3.8

15.28

9.13

mg/mmol

7.12

2528

19622

Inflammatory diseases of female pelvic organs

7803

49302

1.21

43.20

3.9

3.7

8.28

8.69

mg/mmol

0.30

4509

28707

Osteopathies and chondropathies

8563

69507

1.21

42.97

4.3

3.8

15.87

8.35

mg/mmol

19.22

5538

42985

Streptococcal septicaemia

1366

9706

1.64

42.84

4.9

3.7

27.51

7.24

mg/mmol

11.29

980

6147

Other/unspecified cytomegaloviral diseases

340

1699

2.94

42.84

10.2

3.7

30.10

8.74

mg/mmol

4.45

297

1070

Microscopic polyangiitis

155

570

7.65

42.79

17.0

3.9

26.85

8.62

mg/mmol

3.00

146

356

Other diseases of anus and rectum

4672

38770

1.29

42.47

3.9

3.7

11.95

8.77

mg/mmol

3.18

2837

24257

Polycystic ovarian syndrome, broad definition

931

5925

1.69

42.26

3.9

4.1

10.79

13.73

mg/mmol

1.10

625

3952

Amenorrhoea

685

4055

1.87

42.25

4.8

4.0

12.81

12.01

mg/mmol

0.13

442

2616

Type 1 diabetes, strict definition, subgroup 2

17.61

42.22

4.3

2.3

0.63

430.71

mg/mmol

0.49

Failed induction of labour

517

2813

2.04

41.96

4.3

4.2

18.79

12.78

mg/mmol

1.32

391

1889

Non-small cell lung cancer

827

12463

0.58

41.80

3.5

3.8

12.56

9.34

mg/mmol

0.93

532

7971

Tubulo-interstitial nephritis, not specified as acute or chronic

980

6498

1.75

41.76

5.2

3.4

19.51

5.09

mg/mmol

10.96

730

3921

Other symptoms and signs involving the circulatory and respiratory systems

970

6435

1.75

41.54

3.8

14.39

8.04

mg/mmol

2.21

641

4125

Other diseases of intestine

2268

17529

1.45

41.41

4.5

3.8

12.99

8.66

mg/mmol

3.91

1584

11084

Leiomyoma of uterus

8480

41664

1.21

41.41

3.6

7.96

7.67

mg/mmol

0.17

4765

23942

Internal derangement of knee

5544

46562

1.25

41.23

3.9

3.8

9.24

8.47

mg/mmol

0.52

3418

29658

Pre-eclampsia superimposed on chronic hypertension

102

263

6.50

41.00

6.9

3.2

39.90

4.48

mg/mmol

2.42

157

Disorders of vestibular function (Vertigo)

7256

61830

1.22

40.94

3.8

7.56

9.01

mg/mmol

2.16

4297

38133

Sequelae with surgical and medical care as external cause

3062

24567

1.37

40.93

4.2

3.8

15.89

9.13

mg/mmol

6.49

2013

15412

Other viral diseases

4495

36786

1.27

40.86

4.7

3.9

14.22

10.09

mg/mmol

3.44

3109

24102

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1213

8527

1.67

40.79

4.8

3.8

25.14

9.04

mg/mmol

8.32

839

5298

Cardiodefibrillation

5921

50726

1.26

40.32

3.8

3.9

10.36

9.52

mg/mmol

0.45

3900

32526

Keratitis

5083

42716

1.26

40.32

4.4

3.8

10.96

9.05

mg/mmol

1.74

3336

27072

Granulomatous disorders of skin and subcutaneous tissue

413

2225

2.44

40.09

5.7

3.8

17.39

8.67

mg/mmol

1.94

275

1351

Undetermined asthma, excluding more controls

1865

13951

1.47

40.05

4.0

3.6

11.79

6.11

mg/mmol

3.29

1130

8513

Benign neoplasm: Ascending colon

2206

17172

1.47

40.00

4.3

3.8

13.87

9.01

mg/mmol

3.73

1508

10766

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4493

36954

1.27

39.99

3.9

8.70

9.90

mg/mmol

0.74

2881

23995

Retinal detachments and breaks

5575

47507

1.26

39.77

4.3

3.7

12.69

8.17

mg/mmol

7.22

3592

29696

Otitis externa, unspecified

1481

10713

1.55

39.68

4.6

3.9

11.21

9.11

mg/mmol

0.86

989

6909

Candidiasis

1854

13932

1.48

39.45

4.5

3.8

13.85

9.04

mg/mmol

2.66

1216

8701

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6831

58715

1.22

39.30

3.9

4.0

14.86

9.24

mg/mmol

9.57

4470

39147

Benign paroxysmal vertigo

4375

36533

1.29

39.19

3.8

7.88

9.12

mg/mmol

1.09

2580

22393

Other problems related to primary support group, including family circumstances

1169

7781

1.59

39.18

4.5

3.9

24.41

9.92

mg/mmol

0.54

821

5089

Alcohol use disorder, ICD-based

6288

53992

1.23

39.15

3.9

4.0

14.75

9.28

mg/mmol

8.34

4110

35951

Ingrowing nail

744

4715

1.87

39.08

4.9

3.9

15.96

9.33

mg/mmol

2.00

509

3020

Nonalcoholic steatohepatitis

182

735

4.56

38.92

4.9

3.7

5.99

8.20

mg/mmol

0.45

134

455

Open wound of ankle and foot

1420

10246

1.56

38.84

5.2

3.9

25.96

9.34

mg/mmol

10.30

1009

6759

Nail disorders

1140

7924

1.65

38.84

4.6

3.8

15.67

8.82

mg/mmol

2.55

769

5003

Other viral diseases

3490

28148

1.31

38.62

5.0

3.9

14.67

10.48

mg/mmol

2.95

2434

18483

Urticaria and erythema

4738

39621

1.26

38.53

4.2

3.8

11.79

9.71

mg/mmol

1.32

2946

24898

Misadventures to patients during surgical and medical care

2080

15995

1.45

38.50

4.4

3.8

15.42

8.86

mg/mmol

5.26

1416

10075

Other diseases of arteries and capillaries

1332

9588

1.60

38.47

5.5

3.7

25.17

7.68

mg/mmol

11.57

938

6012

Cardiomyopathies, Primary/intrinsic

1882

14317

1.48

38.26

4.0

3.8

13.31

6.38

mg/mmol

6.37

1339

9204

Other symptoms and signs involving the digestive system and abdomen

2420

18923

1.39

38.15

4.1

3.7

9.03

7.73

mg/mmol

0.73

1451

11240

Excessive earwax

8643

74318

1.19

38.04

4.0

3.9

8.71

9.58

mg/mmol

0.67

5367

47177

Use of pramipexole

3325

27151

1.34

37.96

4.3

3.8

11.91

9.02

mg/mmol

2.04

2117

16669

Nondiabetic hypoglycaemic coma

256

8.60

37.81

7.9

4.0

16.96

11.95

mg/mmol

0.29

177

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1623

10425

1.45

37.79

4.1

4.4

13.74

14.88

mg/mmol

0.21

1132

7437

Other/unspecified synovitis and tenosynovitis

1606

11875

1.50

37.69

4.5

3.7

10.27

9.29

mg/mmol

0.28

1041

7435

Other benign neoplasms of skin

5582

47693

1.24

37.62

4.2

3.8

9.40

9.21

mg/mmol

0.10

3485

29553

Gastric ulcer

2766

22119

1.37

37.61

4.3

3.7

15.94

8.91

mg/mmol

7.00

1859

13906

Cytomegalovirus infection, IBD co-morbidity

376

2034

2.54

37.37

9.9

3.8

29.41

8.55

mg/mmol

4.88

322

1277

Alcohol-induced acute pancreatitis

593

3668

2.08

37.32

4.8

3.9

19.91

8.84

mg/mmol

2.79

391

2475

Unspecified urinary incontinence

1303

9402

1.59

37.27

4.2

3.7

11.10

7.97

mg/mmol

0.41

683

5563

Intracranial injury

8776

73095

1.18

36.77

3.8

3.9

10.37

9.53

mg/mmol

0.77

5588

47046

Deforming dorsopathies

3985

33023

1.28

36.74

3.6

3.8

8.58

9.44

mg/mmol

0.42

2425

20429

Diseases of salivary glands

4514

37908

1.27

36.51

4.0

3.8

9.88

9.19

mg/mmol

0.38

2811

23611

Benign neoplasm of other and unspecified endocrine glands

1925

14798

1.46

36.44

4.1

3.8

11.37

9.07

mg/mmol

0.91

1302

9258

Spondylolisthesis/Spondylolysis

2706

21638

1.36

36.38

3.5

3.8

7.09

8.83

mg/mmol

1.24

1639

13318

Pilonidal cyst

1041

7122

1.62

36.34

4.5

3.9

13.17

8.95

mg/mmol

1.52

709

4875

1678

12487

1.46

36.34

4.8

3.7

16.43

8.96

mg/mmol

4.48

1101

7622

Acute peritonitis

946

6477

1.72

36.21

8.7

3.8

46.24

8.72

mg/mmol

17.34

772

4190

Other symptoms and signs involving the nervous and musculoskeletal systems

5980

51399

1.22

36.10

3.8

8.82

9.56

mg/mmol

0.43

3937

32246

Cytomegaloviral disease

383

2104

2.46

36.07

9.8

3.8

29.05

8.87

mg/mmol

4.70

326

1317

Other and unspecified vascular occlusions

1441

10674

1.56

36.01

4.2

3.7

12.22

8.60

mg/mmol

2.41

954

6677

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2909

22887

1.32

36.00

4.2

3.9

16.68

10.45

mg/mmol

0.54

1927

15039

Emotional disorders starting during childhood or adolecense, excluding more controls

318

1483

2.28

36.00

4.1

4.3

13.31

12.76

mg/mmol

0.04

221

1137

Plantar fascial fibromatosis

1356

9845

1.55

35.96

3.8

3.7

6.13

8.34

mg/mmol

1.25

786

5994

Diseases of peritoneum

1467

10843

1.53

35.93

6.9

3.8

35.66

8.93

mg/mmol

16.41

1081

6867

Lichen simplex chronicus and prurigo

944

6477

1.72

35.92

4.4

3.8

16.48

7.89

mg/mmol

2.42

659

4031

Unspecific neurodegenerative disorder

5253

41922

0.81

35.82

3.4

3.8

9.20

9.80

mg/mmol

0.40

3288

26148

Allergic asthma (mode), excluding more controls

2874

22394

1.32

35.82

3.7

8.27

7.15

mg/mmol

0.52

1835

14114

Secondary polycythaemia

402

2259

2.41

35.62

4.6

3.9

13.22

9.02

mg/mmol

0.94

263

1481

Dementia in Alzheimer disease

1667

18589

0.70

35.59

3.1

3.7

10.96

10.26

mg/mmol

0.20

1001

11667

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4306

36043

1.27

35.58

4.0

3.9

11.81

9.45

mg/mmol

2.02

2925

23139

Dysphagia

3830

31850

1.29

35.46

3.9

3.8

8.36

8.55

mg/mmol

0.09

2441

19835

Conjunctivitis (acute, non atopic)

3646

29891

1.29

35.44

4.3

3.8

13.13

10.23

mg/mmol

1.59

2330

19106

Smoking dependency

1257

9091

1.59

35.38

4.3

3.8

16.60

8.86

mg/mmol

3.38

806

5831

Mental and behavioural disorders due to tobacco

1257

9093

1.59

35.34

4.3

3.9

16.60

8.80

mg/mmol

3.44

806

5843

Other disorders of nervous system

1038

7315

1.68

35.14

4.7

3.9

14.68

8.73

mg/mmol

2.39

714

4601

Diseases of inner ear

8469

72434

1.19

35.09

3.8

7.53

9.14

mg/mmol

2.82

5057

45109

Syphilis

420

2391

2.31

35.05

6.6

3.9

36.88

8.93

mg/mmol

5.75

324

1579

Syphilis

420

2391

2.31

35.05

6.6

3.9

36.88

8.93

mg/mmol

5.75

324

1579

Corns and callosities

1004

7008

1.68

35.04

5.2

3.7

20.39

8.18

mg/mmol

7.06

727

4353

Cervicalgia

2966

24001

1.33

34.94

3.6

3.8

8.70

9.15

mg/mmol

0.16

1797

14892

Benign neoplasm: Rectum, anus and anal canal

3140

25778

1.34

34.91

4.0

3.8

10.46

9.22

mg/mmol

0.73

2090

16232

Zoster [herpes zoster]

7655

66243

1.20

34.88

4.1

3.8

10.82

8.88

mg/mmol

2.54

4850

40861

Preterm labour and delivery

2966

23892

1.32

34.87

4.3

3.7

12.24

8.17

mg/mmol

3.05

1829

13734

Failure and rejection of transplanted organs and tissues

243

1155

3.16

34.83

10.5

3.8

26.82

9.24

mg/mmol

5.73

215

721

Primary coxarthrosis, bilateral

4544

38601

1.27

34.79

3.7

3.8

9.32

9.45

mg/mmol

0.05

2857

23760

COPD (mode)

5338

35979

1.25

34.51

4.0

3.7

18.81

6.42

mg/mmol

24.89

3522

22416

Glucosamine medication

7881

55517

1.20

34.46

3.7

3.8

7.59

9.05

mg/mmol

1.60

4516

33709

Undetermined asthma

1865

14270

1.43

34.43

4.0

3.7

11.79

6.76

mg/mmol

2.67

1130

8775

Generalized anxiety disorder

1640

12174

1.43

34.26

3.6

4.0

8.28

10.50

mg/mmol

1.08

1004

8014

Cardiomyopathy (excluding other)

1922

14894

1.44

34.13

4.0

3.8

13.21

6.45

mg/mmol

6.34

1370

9524

Membranous nephropathy

108

364

8.41

33.99

14.8

3.5

53.92

7.51

mg/mmol

8.34

225

Traction detachment of retina

167

684

4.08

33.74

8.6

3.7

39.20

8.71

mg/mmol

3.64

141

446

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1959

15262

1.44

33.72

4.5

3.8

12.18

9.31

mg/mmol

1.44

1321

9692

Other symptoms and signs involving cognitive functions and awareness

7254

57954

1.20

33.67

3.7

3.8

10.11

9.18

mg/mmol

0.80

4535

36556

Pruritus

1467

10890

1.49

33.65

4.5

3.8

16.85

8.36

mg/mmol

4.05

916

6740

Endometriosis

4233

20610

1.26

33.62

3.6

3.7

7.29

10.18

mg/mmol

3.54

2408

12229

Hyperkinetic disorders, excluding more controls

820

5076

1.63

33.55

3.8

4.3

11.93

12.48

mg/mmol

0.10

563

3728

Persons encountering health services in circumstances related to reproduction

6072

47387

0.83

33.38

3.7

3.9

8.67

8.86

mg/mmol

0.09

3847

30146

Radial styloid tenosynovitis [de Quervain]

731

4757

1.76

33.37

4.5

3.7

10.74

8.70

mg/mmol

0.43

480

2915

Social phobias

843

5567

1.64

33.33

3.9

4.1

10.46

11.03

mg/mmol

0.10

530

3810

Benign neoplasm: Rectum

2813

22980

1.35

33.27

4.0

3.8

10.78

9.12

mg/mmol

0.98

1881

14482

Neovascular glaucoma

603

3806

1.92

33.25

5.7

3.6

25.64

8.07

mg/mmol

4.82

445

2414

N06DA Anticholinesterases

4021

37575

0.79

33.15

3.3

3.8

8.35

10.10

mg/mmol

1.68

2464

23439

Use of anticholinesterases

4021

37575

0.79

33.15

3.3

3.8

8.35

10.10

mg/mmol

1.68

2464

23439

Acute upper respiratory infections of multiple and unspecified sites

10996

72971

1.15

33.14

4.3

3.8

13.55

8.92

mg/mmol

2.24

7152

46502

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1415

10549

1.52

33.12

4.2

3.9

20.27

9.34

mg/mmol

5.97

954

6755

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

238

1109

2.82

33.10

5.7

4.0

22.98

9.13

mg/mmol

1.73

177

728

Acute nephritic syndrome

352

1938

2.46

33.04

10.0

3.6

40.95

5.94

mg/mmol

8.23

307

1249

Vascular disorders of the intestines

1075

7694

1.63

32.85

4.4

3.8

19.80

9.41

mg/mmol

5.65

773

4873

Oesophageal varices

675

4455

1.90

32.68

4.6

3.9

13.76

8.04

mg/mmol

1.99

455

2909

Monoamine oxidase A inhibitors

1687

12881

1.45

32.64

3.8

8.15

8.91

mg/mmol

0.24

1010

8024

Speech therapy

3868

32465

1.28

32.63

3.9

3.8

8.87

9.26

mg/mmol

0.23

2965

19991

Donors of organs and tissues

235

1108

2.89

32.54

3.1

3.8

10.49

9.07

mg/mmol

0.10

130

703

Abnormal results of function studies

1221

8890

1.55

32.43

4.6

3.8

12.95

8.95

mg/mmol

1.44

807

5654

Systemic lupus erythematosus

523

3210

2.01

32.40

7.4

3.7

21.73

8.03

mg/mmol

3.24

382

1970

Coagulation defects, purpura and other haemorrhagic conditions

2622

21119

1.34

32.39

4.8

3.8

15.64

10.47

mg/mmol

3.48

1822

13506

L02BA Anti-estrogens

1322

17789

0.69

32.37

3.2

3.6

5.38

7.72

mg/mmol

1.50

686

10143

Thyrotoxicosis, other and/or unspecified

2600

20872

1.34

32.36

4.1

3.7

9.17

9.08

mg/mmol

0.03

1596

12683

Abnormal findings on diagnostic imaging of other body structures

2001

15703

1.41

32.27

4.0

3.8

12.51

8.49

mg/mmol

2.61

1296

9674

Early onset COPD

3420

28490

1.30

32.25

4.0

3.9

16.46

8.74

mg/mmol

6.79

2223

18370

All influenza (not pneumonia)

2034

15877

1.39

32.18

4.4

3.8

15.92

7.76

mg/mmol

6.44

1360

10279

Injuries to the ankle and foot

9753

77321

1.16

32.17

4.2

3.9

12.43

9.34

mg/mmol

5.05

6347

49590

Non-allergic asthma (mode), excluding more controls

2724

21788

1.33

32.03

3.7

3.6

8.22

6.21

mg/mmol

1.64

1724

13318

Thyrotoxicosis

3410

28244

1.29

31.98

4.1

3.7

9.27

9.20

mg/mmol

0.03

2099

17060

Disturbances of skin sensation

3569

29617

1.28

31.95

3.8

9.23

9.29

mg/mmol

0.02

2173

18730

Agoraphobia

352

1871

2.17

31.94

3.9

4.0

11.80

11.48

mg/mmol

0.03

218

1247

Dermatophytosis

1906

14894

1.42

31.94

4.4

3.9

11.63

9.51

mg/mmol

0.88

1320

9641

Post-traumatic stress disorder

781

5112

1.65

31.93

3.5

4.0

10.63

11.69

mg/mmol

0.14

492

3460

Cardiac murmurs and other cardiac sounds

1111

7780

1.54

31.89

4.5

3.8

15.72

10.96

mg/mmol

0.75

707

4925

SLE, ICD10

501

3056

2.03

31.87

7.6

3.7

22.07

7.94

mg/mmol

3.22

368

1859

SLE, strict definition

501

3056

2.03

31.87

7.6

3.7

22.07

7.94

mg/mmol

3.22

368

1859

Prolonged pregnancy

568

8043

0.59

31.84

2.3

3.9

9.47

10.83

mg/mmol

0.22

336

5165

Anxiety disorders

13276

83841

1.14

31.82

3.9

9.66

8.97

mg/mmol

0.74

8381

52934

Triptan medication for migraine, min. 3 purchases

5131

45835

0.83

31.74

3.3

3.9

7.17

9.36

mg/mmol

3.53

3047

28563

Neurotic, stress-related and somatoform disorders

13101

83025

1.14

31.71

3.9

9.68

8.95

mg/mmol

0.80

8277

52391

Allergic asthma (mode)

2874

22720

1.30

31.70

3.7

8.27

7.76

mg/mmol

0.19

1835

14375

Oxycodone

6043

47556

1.21

31.61

3.9

3.7

15.98

7.85

mg/mmol

16.33

3988

29724

Tobacco use

743

4965

1.76

31.53

4.6

3.9

16.93

9.49

mg/mmol

1.97

547

3227

Fungal Sepsis

645

4229

1.88

31.51

5.4

3.7

21.62

6.94

mg/mmol

5.41

478

2630

Other diseases of stomach and duodenum

983

6977

1.65

31.46

4.8

3.7

18.73

8.48

mg/mmol

2.98

691

4349

Dementia

5601

44271

0.82

30.90

3.5

3.9

11.28

9.37

mg/mmol

1.43

3546

27551

Propionic acid derivatives

4273

17941

1.25

30.84

3.8

4.4

9.24

12.61

mg/mmol

2.96

2783

12282

Other viral diseases, not elsewhere classified

3070

24965

1.29

30.79

4.4

3.9

12.68

10.31

mg/mmol

1.02

2116

16303

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2391

11873

1.32

30.67

4.5

3.8

17.42

10.58

mg/mmol

5.71

1717

7748

Other shoulder lesions

1247

9141

1.51

30.66

4.2

3.7

7.14

9.33

mg/mmol

1.48

792

5782

Other viral diseases, not elsewhere classified

2212

17441

1.35

30.60

4.7

3.8

12.69

10.49

mg/mmol

0.74

1530

11357

Other and unspecified effects of external causes

3355

27751

1.27

30.47

4.1

3.9

16.44

10.03

mg/mmol

0.65

2150

17922

Other and unspecified mood [affective] disorders

754

4978

1.66

30.41

3.8

3.9

13.88

10.47

mg/mmol

0.49

483

3311

Enthesopathies of lower limb, excluding foot

3088

25444

1.30

30.38

3.8

6.04

8.85

mg/mmol

4.34

1866

15955

Infective dermatitis

1615

12396

1.45

30.35

4.3

3.8

13.75

8.83

mg/mmol

2.89

1080

7950

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1224

9004

1.52

30.24

4.2

3.8

15.64

10.62

mg/mmol

1.14

783

5669

Complications of internal orthopaedic prosthetic devices, implants and grafts

3471

29159

1.29

29.86

3.8

3.7

13.09

8.34

mg/mmol

3.80

2218

17811

Any event in hilmo or specialist outpatient

104

151

4.36

29.86

3.7

2.8

17.57

0.94

mg/mmol

2.25

111

Other chronic obstructive pulmonary disease, including avohilmo

8826

65351

1.17

29.80

3.9

15.64

8.66

mg/mmol

16.69

5730

41472

Injuries to the thorax

6873

60555

1.19

29.77

4.1

3.9

12.72

9.46

mg/mmol

4.09

4470

39073

Fracture of foot, except ankle

3103

25574

1.29

29.76

4.4

3.9

13.95

9.43

mg/mmol

3.05

1990

16401

Acute suppurative otitis media

2586

19329

1.30

29.76

4.7

4.1

20.80

10.42

mg/mmol

0.94

1731

13081

Acute upper respiratory infections

16426

92883

1.12

29.70

4.2

3.8

12.33

8.95

mg/mmol

2.39

10472

58777

Viral warts

2621

21224

1.31

29.69

5.0

3.9

11.17

9.55

mg/mmol

0.83

1805

13702

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1627

12650

1.46

29.65

4.4

3.9

22.41

8.65

mg/mmol

11.52

1103

8129

Symptoms and signs concerning food and fluid intake

1516

11535

1.45

29.63

4.2

3.8

13.36

7.88

mg/mmol

2.70

964

7189

In situ neoplasms

5546

48241

1.21

29.54

4.2

3.7

9.77

9.48

mg/mmol

0.18

3491

29600

Implicit fungal Sepsis

593

3877

1.89

29.43

5.5

3.7

22.55

6.98

mg/mmol

5.24

440

2412

Hirsutism in women

222

1037

2.61

29.29

4.5

3.9

8.74

11.19

mg/mmol

0.35

141

662

Calcific tendinitis of shoulder

806

5550

1.67

29.21

3.8

3.6

7.28

7.39

mg/mmol

0.03

493

3440

Female infertility, associated with anovulation

649

4139

1.68

29.20

3.9

4.1

11.50

13.88

mg/mmol

0.61

446

2770

Mental disorders, not otherwise specified

927

6479

1.57

28.96

3.8

3.9

10.72

10.55

mg/mmol

0.02

577

4197

Nonorganic sleeping disorders

2389

19177

1.32

28.95

3.7

3.9

8.37

9.92

mg/mmol

0.99

1510

12456

COPD related to multimorbidity

6450

48041

1.20

28.92

4.1

3.9

17.04

9.14

mg/mmol

15.47

4309

30693

Hypertrichosis

252

1245

2.44

28.84

4.5

3.8

8.03

10.61

mg/mmol

0.44

165

788

Lateral epicondylitis

1779

13861

1.40

28.81

3.8

3.7

5.32

8.40

mg/mmol

3.52

1128

8729

Somatoform disorder

2082

16518

1.36

28.71

3.8

6.72

9.20

mg/mmol

2.12

1235

10326

Benign neoplasm: Descending colon

1092

8083

1.59

28.66

4.5

3.9

11.28

9.13

mg/mmol

0.76

781

5134

Congenital malformations, deformations and chromosomal abnormalities

7613

64151

1.17

28.63

4.6

3.9

13.43

9.52

mg/mmol

1.10

5194

40976

Other enthesopathy of foot (+metatarsalgia)

1348

10120

1.47

28.61

3.8

3.7

8.50

8.77

mg/mmol

0.06

803

6181

Abnormalities of gait and mobility

1791

14123

1.42

28.56

4.2

3.9

13.18

10.47

mg/mmol

0.84

1191

9006

Other and unspecified tonsillitis

3862

27235

1.24

28.35

4.0

3.9

12.07

9.73

mg/mmol

1.51

2685

18641

Cyst of kidney

1097

8133

1.58

28.22

4.6

3.8

18.26

8.61

mg/mmol

5.48

774

5161

Erosion of teeth , including avohilmo

2941

24210

1.28

28.14

4.5

3.9

11.65

9.94

mg/mmol

0.73

1829

15777

Systemic lupus erythematosus, unspecified

431

2613

2.05

28.13

6.7

3.7

20.94

8.07

mg/mmol

2.26

309

1577

Other and unspecified drugs and medicaments

1153

8517

1.52

28.12

4.2

3.9

14.85

9.04

mg/mmol

2.63

743

5372

Type of accident

3942

33445

1.24

28.10

4.0

3.9

11.65

9.50

mg/mmol

1.69

2678

21451

Other obstetric conditions, not elsewhere classified

2453

12385

1.30

27.95

4.4

3.8

17.06

10.43

mg/mmol

5.60

1755

8033

Urticaria

3660

30795

1.25

27.78

4.2

3.8

12.08

9.94

mg/mmol

1.04

2285

19392

Allergic purpura

413

2462

2.03

27.75

6.0

4.0

20.08

9.59

mg/mmol

2.54

320

1579

Oligomenorrhoea

409

2392

1.97

27.74

4.4

3.9

9.47

10.65

mg/mmol

0.22

254

1475

Disorders of psychological development

1007

6583

1.50

27.73

3.9

4.2

10.25

15.16

mg/mmol

1.01

691

4601

Myocardial infarction, with ST-elevation

2678

22107

1.32

27.63

4.1

3.9

15.57

10.00

mg/mmol

4.43

1792

14470

Alcohol abuse, main dg, excluding more controls

1967

15581

1.36

27.60

4.0

3.9

15.09

8.33

mg/mmol

4.68

1291

10519

Viral pneumonia (unknown virus, not influenza)

914

6507

1.59

27.39

5.2

3.9

18.53

11.93

mg/mmol

1.10

622

4225

Chronic sinusitis

6099

53489

1.19

27.38

4.0

3.8

8.47

8.99

mg/mmol

0.25

3681

33767

Coxarthrosis, primary, with hip surgery

7611

63704

1.18

27.32

3.7

3.8

8.69

9.05

mg/mmol

0.27

4772

39367

Mental retardation, excluding more controls

431

2501

1.93

27.20

4.0

3.8

13.83

14.09

mg/mmol

0.01

289

1665

Glaucoma secondary to other eye disorders

604

4003

1.80

27.18

5.7

3.8

25.59

8.95

mg/mmol

4.39

446

2575

Pain associated with micturition

1569

12154

1.42

27.16

4.1

3.7

9.99

9.90

mg/mmol

0.02

971

7538

Adverse effects, not elsewhere classified

2373

19202

1.31

27.11

4.2

3.9

19.43

9.60

mg/mmol

0.71

1483

12164

Other noninfective gastroenteritis and colitis

3236

27060

1.26

26.80

4.2

3.8

20.23

9.53

mg/mmol

1.33

2126

17052

Follicular cysts of skin and subcutaneous tissue

2507

20550

1.31

26.67

4.2

3.8

11.91

9.29

mg/mmol

1.24

1693

13198

Speech and linguistic disorders, excluding more controls

716

4485

1.61

26.63

4.0

4.1

10.27

14.46

mg/mmol

0.52

505

3114

Renal agenesis and other reduction defects of kidney

342

5.15

26.60

9.7

3.8

37.28

12.79

mg/mmol

1.92

220

Purpura and other haemorrhagic conditions

1823

14442

1.38

26.60

4.8

3.8

15.78

11.06

mg/mmol

1.86

1281

9259

Left bundle-branch block

1092

8105

1.53

26.57

4.2

3.7

10.06

5.67

mg/mmol

1.71

655

4988

Zoster [herpes zoster]

2624

21684

1.31

26.37

4.6

3.8

13.52

9.13

mg/mmol

3.32

1728

13391

Other renal tubulo-interstitial diseases

337

1928

2.15

26.34

5.8

3.3

28.51

5.37

mg/mmol

3.49

249

1160

Non-allergic asthma (mode)

2724

22255

1.29

26.33

3.7

8.22

7.20

mg/mmol

0.59

1724

13753

Metatarsalgia

1251

9418

1.46

26.21

3.8

3.7

8.94

8.80

mg/mmol

0.03

737

5746

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7789

67654

1.16

26.12

3.9

8.52

9.54

mg/mmol

0.93

4862

43619

Benign neoplasm: Stomach

1423

11035

1.45

26.08

4.2

3.8

11.56

8.72

mg/mmol

1.05

875

6758

L04AX Other immunosuppressants

8083

72417

1.16

26.07

4.4

3.8

12.58

8.81

mg/mmol

1.10

5405

45210

Neuromuscular dysfunction of bladder

1302

9931

1.47

26.03

4.1

3.8

14.58

8.47

mg/mmol

2.39

835

6310

Lyme disease

3157

37423

0.80

25.90

3.5

3.8

7.02

8.94

mg/mmol

0.72

1774

23223

Second line medication for Crohn's disease

8277

74273

1.15

25.87

4.4

3.8

12.62

8.80

mg/mmol

1.16

5543

46408

Spirochaetal infections, other/unspecified

3184

37706

0.80

25.82

3.6

3.8

6.96

8.92

mg/mmol

0.75

1797

23398

Psoriasis (vulgaris), strict definition

476

3021

1.90

25.75

4.1

3.9

12.02

8.85

mg/mmol

0.58

319

1983

Schizotypal disorder

309

1724

2.18

25.74

3.4

4.0

3.34

9.89

mg/mmol

4.88

178

1117

Other spirochaetal diseases

3193

37777

0.80

25.59

3.6

3.8

7.10

8.92

mg/mmol

0.68

1800

23445

Diabetic nephropathy, excluding more controls

4412

32853

1.37

25.48

8.7

4.2

52.60

4.05

mg/mmol

166.01

3899

22144

Emotional disorders and disorders of social functioning with onset specific to childhood

341

1857

1.94

25.48

4.1

4.5

14.91

14.07

mg/mmol

0.06

231

1401

Iridocyclitis

3089

25927

1.27

25.46

4.3

3.8

14.44

9.12

mg/mmol

4.31

2041

16428

Supervision of normal pregnancy

1220

9391

0.71

25.42

2.7

3.8

8.82

7.38

mg/mmol

0.51

768

5748

Macular pucker

2382

19725

1.34

25.39

4.2

3.7

11.25

8.26

mg/mmol

2.32

1454

12208

Disorders of muscles

1347

10294

1.43

25.35

3.9

3.7

10.67

9.64

mg/mmol

0.32

870

6597

Other systemic involvement of connective tissue

3815

32627

1.24

25.31

3.9

3.7

9.02

9.08

mg/mmol

0.02

2399

19736

Fall on same level involving ice and snow

8390

75493

1.15

25.29

4.0

3.8

9.82

9.05

mg/mmol

0.62

5249

47269

Eating disorder

699

4677

1.59

25.25

4.5

4.1

10.53

13.41

mg/mmol

0.72

450

3247

Other hearing loss

4143

34931

1.23

25.17

4.0

3.7

10.12

10.69

mg/mmol

0.26

2436

22009

Lichen sclerosus et atrophicus

1407

10892

1.43

25.14

4.0

3.6

5.73

7.70

mg/mmol

1.24

851

6252

Other diseases of blood and blood-forming organs

995

7355

1.55

25.13

4.2

3.9

14.01

9.10

mg/mmol

1.78

612

4673

Disorders of ocular muscles, binocular movement, accommodation and refraction

6052

52844

1.18

25.10

4.0

3.9

10.82

9.65

mg/mmol

0.73

3848

33688

Migraine without aura

1883

14847

1.33

25.06

3.8

3.9

6.63

10.11

mg/mmol

4.06

1158

9434

Unspecified acute lower respiratory infection

1988

15972

1.34

25.05

4.1

3.9

14.31

9.42

mg/mmol

3.39

1435

10564

Brachial plexus disorders

1072

7893

1.48

25.04

3.5

3.6

5.17

8.02

mg/mmol

1.69

673

4977

Pustular psoriasis

659

4526

1.71

24.99

4.1

3.7

8.75

8.55

mg/mmol

0.04

401

2750

Fissure and fistula of anal and rectal regions

3453

29302

1.25

24.97

4.0

3.8

8.95

8.65

mg/mmol

0.13

2076

18643

Other complications of surgical and medical care, not elsewhere classified

1297

9901

1.44

24.94

4.0

3.8

14.85

7.93

mg/mmol

3.41

834

6183

Other eating disorders

423

2532

1.82

24.84

4.6

4.2

9.29

12.69

mg/mmol

0.67

277

1779

Use of biperiden

742

5216

1.65

24.80

3.8

8.57

8.53

mg/mmol

0.01

456

3315

Radiculopathy

2334

19149

1.31

24.79

3.8

10.96

9.64

mg/mmol

0.42

1455

11968

Primary open-angle glaucoma

4899

41457

1.21

24.78

4.0

3.7

10.33

9.41

mg/mmol

0.49

3005

25572

Convulsions, not elsewhere classified

3096

25601

1.25

24.78

4.4

3.9

13.66

7.96

mg/mmol

6.14

2039

16607

Chronic rhinitis, nasopharyngitis and pharyngitis

4325

37318

1.21

24.77

4.0

3.9

8.43

9.60

mg/mmol

0.74

2595

23590

Amputation of ankle bones

350

2098

2.15

24.70

7.5

3.8

61.43

9.42

mg/mmol

11.17

289

1388

Coeliac disease

1548

12093

1.39

24.70

5.0

3.8

14.74

10.06

mg/mmol

1.13

992

7601

Use of disulfiram, acamprosate or naltrexone

1172

8850

1.47

24.67

3.6

3.9

8.77

9.54

mg/mmol

0.18

702

5945

Psychotic depression

777

5447

1.59

24.52

3.9

9.29

9.42

mg/mmol

0.02

489

3485

Eating disorders

943

6743

1.49

24.46

4.5

4.0

11.61

12.36

mg/mmol

0.16

626

4573

Subjective visual disturbances

3425

29109

1.25

24.45

3.8

8.16

9.38

mg/mmol

0.72

2050

18088

Chronic hepatitis, not elsewhere classified

490

3179

1.86

24.39

4.6

3.8

12.50

7.10

mg/mmol

1.10

328

1954

Superficial injury of head

3202

27014

1.25

24.35

3.8

10.54

10.14

mg/mmol

0.13

2026

17277

Other spirochaetal diseases

3253

38263

0.81

24.32

3.6

3.8

7.05

8.90

mg/mmol

0.71

1847

23753

Corneal ulcer

2394

19672

1.30

24.29

4.6

3.8

11.10

9.57

mg/mmol

0.66

1590

12669

Seborrhoeic dermatitis

1326

10228

1.44

24.24

4.5

3.9

11.32

8.95

mg/mmol

0.99

899

6655

Hypopituitarism

861

6179

1.55

24.18

4.1

3.9

9.80

9.14

mg/mmol

0.11

579

4128

Other and unspecified vasculitis limited to skin

374

2295

2.08

24.18

5.2

3.6

16.44

8.91

mg/mmol

1.61

271

1423

Type 1 diabetes, wide definition, subgroup 2

154

658

2.72

24.07

5.8

2.2

13.59

41.94

mg/mmol

0.45

114

367

Other bacterial intestinal infections

3158

26677

1.25

24.06

4.5

3.7

19.33

8.87

mg/mmol

11.69

2093

16732

Hypercalcemia

652

4548

1.73

23.97

5.2

3.8

45.61

8.30

mg/mmol

0.95

476

2788

Noninfectious colitis NAS

1762

14032

1.36

23.97

4.3

3.8

15.49

9.37

mg/mmol

3.65

1182

8854

Pustulosis palmaris et plantaris

598

4062

1.74

23.96

4.2

3.7

8.52

8.40

mg/mmol

0.02

363

2479

Malignant neoplasm of urinary organs

1503

11888

1.42

23.92

4.3

3.9

23.13

8.55

mg/mmol

11.61

1013

7638

Primary open-angle glaucoma, strict

3999

34561

1.23

23.75

4.1

3.7

10.30

9.31

mg/mmol

0.62

2437

21188

Meralgia paraesthetica

497

3268

1.83

23.50

3.7

3.6

7.21

8.51

mg/mmol

0.25

292

2036

Mental and behavioural disorders due to sedatives or hypnotics

826

5913

1.55

23.45

3.7

3.9

13.10

9.26

mg/mmol

0.91

498

3819

Disorder of pancreatic internal secretion, other and/or unspecified

139

625

3.61

23.42

6.3

3.8

7.80

9.15

mg/mmol

0.21

101

391

Polyhydramnios

418

2550

1.81

23.39

4.7

3.9

8.37

11.73

mg/mmol

0.92

316

1617

Use of donepezil

2070

24145

0.77

23.39

3.2

3.7

8.80

10.07

mg/mmol

0.59

1277

15061

Drug-induced obesity

140

612

3.19

23.24

3.9

3.7

10.16

11.30

mg/mmol

0.08

373

Atrophic disorders of skin

1914

15480

1.33

23.13

4.1

3.6

7.14

7.70

mg/mmol

0.22

1144

9050

Non-small cell lung cancer, adenocarcinoma

485

7209

0.59

23.07

3.4

3.9

12.78

8.29

mg/mmol

0.99

318

4541

Vasculitis limited to skin, not elsewhere classified

404

2556

1.97

23.05

5.1

3.6

16.03

8.62

mg/mmol

1.72

289

1586

Leisure time condition

2353

19421

1.29

23.01

4.0

3.8

11.70

9.83

mg/mmol

0.91

1563

12453

Recurrent and persistent haematuria

146

661

3.20

23.01

8.8

3.6

29.58

9.09

mg/mmol

2.71

123

420

Other bursopathies

1863

15064

1.34

22.96

4.0

3.7

12.22

9.08

mg/mmol

1.34

1173

9442

Mental retardation

431

2679

1.82

22.93

4.0

13.83

15.72

mg/mmol

0.10

289

1773

Malignant neoplasm of kidney, except renal pelvis

1379

10865

1.43

22.79

4.4

3.8

23.82

8.45

mg/mmol

11.19

923

6960

Persons encountering health services for specific procedures, not carried out

1046

7815

1.47

22.78

4.3

3.7

16.24

7.37

mg/mmol

3.76

688

4949

Barrett oesophagus

775

5641

1.63

22.71

4.1

3.8

12.68

8.04

mg/mmol

0.90

515

3658

Nontoxic multinodular goitre

2707

22741

1.27

22.69

3.8

3.6

7.60

8.18

mg/mmol

0.28

1613

13264

Hydrocele

1704

13660

1.36

22.69

4.5

3.9

11.09

11.68

mg/mmol

0.13

1222

9352

Orchitis and epididymitis

1315

10220

1.42

22.67

4.5

4.0

11.08

9.87

mg/mmol

0.33

926

7060

Nonischemic cardiomyopathy

1361

10624

1.41

22.63

4.2

3.8

12.63

8.04

mg/mmol

2.90

952

6713

Noninflammatory disorders of female genital tract

4904

21324

1.19

22.59

3.8

3.7

9.31

10.25

mg/mmol

0.57

2976

12786

Drug-induced cataract

358

2212

2.05

22.55

7.2

3.8

23.88

7.12

mg/mmol

4.53

266

1363

Rheumatoid arthritis

4594

35960

1.20

22.49

3.8

3.7

10.95

8.02

mg/mmol

3.14

2994

22090

Short Achilles tendon (acquired)

391

2439

1.92

22.46

2.9

3.6

10.80

7.91

mg/mmol

0.35

209

1474

Congenital malformations, deformations and chromosomal abnormalities

8461

70396

1.14

22.42

4.5

3.8

13.18

9.43

mg/mmol

1.18

5688

44812

Chronic laryngitis and laryngotracheitis

1951

15898

1.33

22.38

4.1

3.8

9.10

9.40

mg/mmol

0.09

1115

10065

Benign neoplasm: Skin of eyelid, including canthus

2197

18165

1.31

22.38

4.0

3.8

8.96

8.98

mg/mmol

0.00

1371

11229

Pain in thoracic spine

1976

16043

1.32

22.36

3.5

3.8

9.03

9.86

mg/mmol

0.28

1221

10074

Other symptoms and signs involving the urinary system

1482

11737

1.39

22.32

4.2

3.8

13.33

8.43

mg/mmol

2.27

1122

7616

Other extrapyramidal and movement disorders in other diseases

3374

28938

1.24

22.31

3.9

3.8

8.36

9.40

mg/mmol

0.58

2066

17991

Pain and other conditions associated with female genital organs and menstrual cycle

2022

14989

1.29

22.24

3.9

3.8

7.94

10.69

mg/mmol

1.72

1188

9138

Amyloidosis

340

2078

2.07

22.20

5.0

3.5

74.48

6.78

mg/mmol

9.97

255

1277

Excessive vomiting in pregnancy

735

5141

1.54

22.15

4.1

3.6

12.13

9.80

mg/mmol

0.42

461

3037

Other epidermal thickening

618

4299

1.68

21.99

4.6

3.7

19.18

8.03

mg/mmol

2.24

452

2694

Amyloidosis, other/unspecified

291

1721

2.23

21.92

5.4

3.5

79.23

6.48

mg/mmol

9.08

222

1047

Suppurative and unspecified otitis media

3895

29634

1.20

21.90

4.6

4.0

17.56

10.55

mg/mmol

0.94

2590

19692

Anti-inflammatory and antirheumatic products, non-steroids

4158

17943

1.21

21.90

3.9

4.4

10.42

12.61

mg/mmol

1.35

2724

12284

Other bacterial intestinal infections

2493

20827

1.28

21.82

4.7

3.7

22.00

9.01

mg/mmol

12.29

1701

13068

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

768

5481

1.54

21.82

4.0

3.9

12.91

10.34

mg/mmol

0.46

494

3584

Acquired absence of limb

174

875

2.89

21.79

7.0

3.7

39.35

8.83

mg/mmol

4.14

135

569

Psoriatic arthropathies

1349

10548

1.39

21.67

3.8

3.7

11.72

8.37

mg/mmol

1.22

886

6715

Psoriatic and enteropathic arthropathies

1523

12074

1.36

21.67

3.8

3.7

11.30

8.38

mg/mmol

1.10

1008

7655

Hypertrophy of breast in women and men

2341

19381

1.28

21.65

3.6

3.7

7.51

8.63

mg/mmol

0.48

1354

11664

Emotional disorders starting during childhood or adolescence

319

1807

1.88

21.65

4.1

4.4

13.25

14.39

mg/mmol

0.09

222

1363

Infections of genitourinary tract in pregnancy

963

7111

1.46

21.64

4.0

3.7

7.74

10.00

mg/mmol

1.01

639

4153

Unspecified fall

7212

63957

1.15

21.50

4.0

3.8

12.93

9.54

mg/mmol

3.78

4555

40701

Squamous cell neoplasms and carcinomas of the skin

1241

9685

1.43

21.46

4.6

3.8

14.46

9.23

mg/mmol

1.99

821

6143

Other obstructive and reflux uropathy

526

3515

1.69

21.33

5.6

3.5

26.22

5.70

mg/mmol

6.04

418

2218

Degenerative macular diseases

1725

13999

1.35

21.30

4.4

3.6

12.92

8.61

mg/mmol

2.78

1096

8599

Later onset COPD

3499

32157

0.82

21.26

3.8

3.9

18.76

9.54

mg/mmol

11.19

2341

20501

Other female pelvic inflammatory diseases

1962

16026

1.31

21.24

3.8

3.6

8.35

8.11

mg/mmol

0.07

1082

9161

Other and unspecified urticaria

2334

19348

1.27

21.22

4.2

3.8

12.96

10.41

mg/mmol

0.83

1472

12210

Nummular dermatitis

1147

8866

1.44

21.14

4.3

3.9

16.00

8.64

mg/mmol

1.99

761

5715

Abnormal blood-pressure reading, without diagnosis

605

4197

1.64

20.97

3.3

3.7

9.73

7.44

mg/mmol

0.85

365

2568

Non-small cell lung cancer, adenocarcinoma, helper endpoint

485

7084

0.61

20.97

3.4

3.8

12.78

8.86

mg/mmol

0.80

318

4514

Noninfective enteritis and colitis

6310

56336

1.16

20.96

4.2

3.9

14.97

9.20

mg/mmol

1.41

4148

35893

Visual impairment including blindness (binocular or monocular)

914

6825

1.49

20.82

5.3

3.8

17.60

9.78

mg/mmol

3.37

593

4314

Erythema intertrigo

354

2223

1.99

20.79

4.6

3.8

13.58

8.72

mg/mmol

0.68

251

1389

Spontaneous rupture of synovium and tendon

1158

8968

1.43

20.78

4.0

3.7

11.61

9.20

mg/mmol

0.65

741

5570

Abscess of anal and rectal regions

1129

8670

1.42

20.70

4.4

3.9

11.81

11.36

mg/mmol

0.07

792

5777

Hepatocellular carcinoma, including Hilmo

463

3113

1.84

20.70

4.4

3.9

13.51

7.70

mg/mmol

1.79

329

2079

Other obstructed labour

832

6077

1.50

20.64

4.2

3.7

6.41

8.32

mg/mmol

0.62

530

3604

Stomatitis and related lesions

2443

20435

1.27

20.63

4.0

3.8

11.52

9.86

mg/mmol

0.63

1511

12936

Mental retardation, wide definition

457

2958

1.73

20.62

4.0

3.9

13.30

14.98

mg/mmol

0.09

306

1940

Infections with a predominantly sexual mode of transmission

3187

27074

1.22

20.60

4.8

3.9

15.09

10.08

mg/mmol

3.79

2109

17453

Alzheimer’s disease (Late onset), excluding more controls

1637

13264

0.76

20.43

3.3

3.7

10.90

8.03

mg/mmol

1.21

1014

8049

Ulcer of oesophagus

1033

7939

1.47

20.40

4.1

3.8

12.47

9.23

mg/mmol

1.16

709

5130

Abnormal findings on diagnostic imaging of lung

7662

66693

1.15

20.38

4.1

3.8

13.41

9.09

mg/mmol

5.40

5003

41886

Malignant neoplasm of breast, HER-negative

1957

23194

0.78

20.16

3.4

3.6

5.86

6.89

mg/mmol

0.66

1003

13016

Diplopia

1777

14512

1.33

20.09

4.0

3.8

9.41

9.44

mg/mmol

0.01

1115

9234

Other specified disorders of kidney and ureter

469

3156

1.78

20.06

6.4

3.8

28.65

8.41

mg/mmol

4.88

350

1981

Benign neoplasm: Caecum

1581

12869

1.37

19.91

4.2

3.8

13.05

9.49

mg/mmol

1.69

1072

8052

Presbycusis

1965

16057

1.30

19.88

3.9

3.7

10.23

10.37

mg/mmol

0.05

1064

10103

Strabismus

3227

27609

1.22

19.86

4.1

3.9

11.78

9.50

mg/mmol

1.19

2102

17660

Faecal incontinence

1307

10346

1.39

19.86

3.7

3.6

12.81

7.50

mg/mmol

1.53

704

5981

Cholangitis (primary sclerosing, PSC)

823

6097

1.51

19.82

4.5

3.8

11.26

9.10

mg/mmol

0.42

556

3871

Hypogonadotropic hypogonadism

371

2353

1.86

19.77

4.0

6.73

10.25

mg/mmol

0.82

254

1648

Heartburn

1479

11833

1.35

19.65

3.7

3.8

9.92

8.48

mg/mmol

0.47

900

7469

Mild mental retardation

299

1784

1.97

19.64

3.8

4.0

13.97

9.86

mg/mmol

0.40

202

1195

Carcinoma in situ of skin of trunk

495

3424

1.78

19.60

4.9

3.8

12.63

9.05

mg/mmol

0.91

330

2220

Enlarged lymph nodes

2154

17907

1.28

19.59

4.1

3.8

11.06

7.74

mg/mmol

2.26

1492

11245

Fracture of rib(s), sternum and thoracic spine

4429

39078

1.19

19.58

4.1

3.9

12.21

9.32

mg/mmol

2.83

2899

25227

Diabetic nephropathy

4449

40325

1.31

19.56

8.7

4.5

52.60

5.77

mg/mmol

156.07

3931

27948

Personal history of other diseases and conditions

1043

7850

1.40

19.54

5.2

3.6

17.73

8.62

mg/mmol

2.99

655

4991

Specific development disorders of scholastic skills

318

1858

1.82

19.36

4.0

4.3

12.81

13.51

mg/mmol

0.08

225

1357

Malignant neoplasm of breast, ER-negative, including Hilmo

2218

25151

0.79

19.35

3.4

3.6

6.10

6.98

mg/mmol

0.53

1150

14174

Haemorrhoids and perianal venous thrombosis

4827

42702

1.18

19.35

3.8

3.7

9.56

8.49

mg/mmol

0.66

2999

26630

Dissociative [conversion] disorders

409

2626

1.74

19.29

3.8

3.9

7.48

10.00

mg/mmol

0.53

252

1694

Bulimia nervosa (incl. atypical)

287

1663

1.90

19.29

4.4

4.2

9.32

14.29

mg/mmol

1.03

178

1138

Dementia, including avohilmo

6155

46929

0.86

19.25

3.6

3.9

11.24

9.46

mg/mmol

1.42

3922

29202

Acute and subacute iridocyclitis

2531

21410

1.25

19.25

4.4

3.8

14.93

9.37

mg/mmol

3.78

1692

13619

Other general symptoms and signs

599

4142

1.58

19.22

4.3

3.8

7.32

7.83

mg/mmol

0.15

344

2600

Other disorders of bladder

1757

14456

1.33

19.17

4.4

3.8

14.61

8.72

mg/mmol

2.90

1071

9257

Migraine with aura

2502

20964

1.24

19.14

3.4

3.8

8.59

10.20

mg/mmol

0.73

1490

13112

Hypocalcemia

338

2147

1.97

19.14

6.2

3.8

31.21

9.04

mg/mmol

4.91

246

1354

Maternal care for known or suspected abnormality of pelvic organs

2266

12734

1.26

19.08

4.5

3.7

13.19

9.14

mg/mmol

2.84

1529

7832

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin/Creatinine [Ratio] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS